Applications including "UV"

LT207 - Anaysis of Antioxidant capacity by post-column HPLC using DPPH radical -

LC Technical Note InertSustain C18
LT205 - Anaysis of stable radical DPPH -

LC Technical Note InertSustainSwift C8
LT201 - Analysis of nitrosoamines by LC-MS / MS, HPLC using InertSustain AQ-C18 -Comparison with PFP column- -

LC Technical Note InertSustain AQ-C18 InertSustain PFP
LT198 - Analysis of ergothioneine in shiitake mushrooms by HPLC -

LC Technical Note InertSustain PFP
LT197 - Analysis of capsaicin by HPLC and LC/MS/MS -

LC Technical Note InertSustain C18
LT195 - Eighteenth revision Japanese Pharmacopoeia analysis of tranexamic acid -2.00 Condition change within the range specified in the general chromatography- -

LC Technical Note InertSustain AQ-C18
ST030 - Analysis of cyromazine in livestock products -

SPE Technical Note InertSustain C18
LB263 - Analysis of Losartan Potassium and Hydrochlorothiazide (Under the Condition of the Japanese Pharmacopoeia, Losartan Potassium and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil C8-3
LB206 - Analysis of Paroxetine hydrochloride (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil TMS
LB161 - Analysis of Clopidogrel sulfate (InertSustain C18) (Under the Condition of the Japanese Pharmacopoeia, Clopidogrel sulfate Tablets) -

LC InertSearch InertSustain C18
LB099 - Analysis of p-Hydroxybenzoic acid n-butyl ester (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB094 - Analysis of Pranlukast hydrate (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C8
LB085 - Analysis of Olmesartan medoxomil (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-2
LB031 - Analysis of Preservatives and Sweetener -

LC InertSearch InertSustain Phenyl
LA908 - Analysis of 17 Anti-depressant drugs (InertSustain C18) -

LC InertSearch InertSustain C18
LC110 - Analysis of Quinic acid, Malic acid, Citric acid, Shikimic acid (Under the Condition of draft for USP, Aronia melanocarpa Fruit Aqueous Dry Extract, IDENTIFICATION C.HPLC PROFILE AND RATIO OF ORGANIC ACIDS) -

LC InertSearch InertSustain AQ-C18
LC109 - Analysis of Prazosin hydrochloride (Under the Condition of draft for USP, Prazosin Hydrochloride Compounded Oral Suspension, ASSAY) -

LC InertSearch InertSustainC18
LC108 - Analysis of Formoterol fumarate (Under the Condition of draft for USP, Formoterol Fumarate Inhalation Solution, Assay) -

LC InertSearch InertCore C8
LC107 - Analysis of Terbinafine hydrochloride (Under the Condition of USP41-NF36,Terbinafine Tablets, IMPURITIES (LIMIT OF TERBINAFINE DIMER)) -

LC InertSearch Inertsil Hybrid-C18
LC105 - Analysis of Cefalexin (Under the Condition of Japanese Pharmacopoeia 18th, Cefalexin,Purity(3) Related substances ) -

LC InertSearch InertSustainSwift C18
LC100 - Analysis of Omeprazole(Under the Condition of USP41-NF36, Omeprazole Delayed-Release Capsules, ASSAY) -

LC InertSearch InertSustain C8
LC099 - Analysis of Ascorbic acid (Under the Condition of draft for USP, Water-Soluble Vitamins Chewable Gels, Ascorbic acid, Method 1) -

LC InertSearch InertSustain C8
LC098 - Analysis of Tramadol Hydrochloride (Under the Condition of draft for USP, Tramadol Hydrochloride Tablets, ASSAY) -

LC InertSearch InertSustain C8
LC096 - Analysis of Adapalene (Under the Condition of draft for USP, Adapalene Cream,ORGANIC IMPURITIES) -

LC InertSearch InertSustainSwift C18
LC095 - Analysis of Adapalene (Under the Condition of draft for USP, Adapalene Cream,ASSAY) -

LC InertSearch InertSustainSwift C18
LC094 - Analysis of Steroids -

LC InertSearch Inertsil Hybrid-C18
LC093 - Analysis of Phytosterols -

LC InertSearch Inertsil Hybrid-C18
LC092 - Analysis of Oligonucleotides -

LC InertSearch Inertsil Hybrid-C18
LC091 - Analysis of Oligonucleotides -

LC InertSearch Inertsil Hybrid-C18
LC090 - Analysis of Oligonucleotides -

LC InertSearch Inertsil Hybrid-C18
LC089 - Analysis of Nucleobases and Nucleosides -

LC InertSearch Inertsil Hybrid-C18
LC088 - Analysis of Nucleobases and Nucleosides -

LC InertSearch Inertsil Hybrid-C18
LC087 - Analysis of Coenzyme A (CoA) -

LC InertSearch Inertsil Hybrid-C18
LC086 - Analysis of Antiviral drugs -

LC InertSearch Inertsil Hybrid-C18
LC085 - Analysis of Antiviral drug nucleosides -

LC InertSearch Inertsil Hybrid-C18
LC084 - Analysis of Antihistamines -

LC InertSearch Inertsil Hybrid-C18
LC083 - Analysis of Antidepressants -

LC InertSearch Inertsil Hybrid-C18
LC082 - Analysis of phytosterols -

LC InertSearch InertCore Plus C18
LC081 - Analysis of 16 kinds of Aldehydes(Detected by Pre-Column Method with DNPH) -

LC InertSearch InertCore C8
LC080 - Analysis of Nucleobases and Nucleosides -

LC InertSearch InertCore Biphenyl
LC079 - Analysis of Decitabine -

LC InertSearch InertCore Biphenyl
LC078 - Analysis of Cyclic nucleotides -

LC InertSearch InertCore Biphenyl
LC077 - Analysis of Components of coffee -

LC InertSearch InertCore Biphenyl
LC076 - Analysis of Antiviral drugs -

LC InertSearch InertCore Biphenyl
LC075 - Analysis of Antiviral drugs -

LC InertSearch InertCore Biphenyl
LC074 - Analysis of Abscisic acid -

LC InertSearch InertCore Biphenyl
LC073 - Analysis of Yohimbine Hydrochloride(Under the Condition of USP41-NF36,Yohimbine Injection, ASSAY) -

LC InertSearch InertSustain C18
LC072 - Analysis of Vitamin K１ (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,PHYTONADIONE) -

LC InertSearch InertSustain C18
LC071 - Analysis of Acetaminophen(Under the Condition of USP41-NF36, Acetaminophen Oral Solution, ASSAY) -

LC InertSearch Inertsil WP300 C18
LC070 - Analysis of Vitamin A (Under the Condition of USP4１-NF3６, Oil- and Water-Soluble Vitamins Capsules,Vitamin A,Method 1) -

LC InertSearch InertSustain NH2
LC069 - Analysis of Catecholamines and it's Metabolites -

LC InertSearch InertSustain PFP
LC068 - Analysis of Gliclazide (Under the Condition of the draft for Japanese Pharmacopoeia, Gliclazide Tablets, ASSAY) -

LC InertSearch Inertsil WP300 C18
LC067 - Analysis of Rebamipide (Under the Condition of the Japanese Pharmacopoeia 18th, Rebamipide, Purity (4) Related Substances -

LC InertSearch Inertsil ODS-3
GA388 - Analysis of Pesticides -

GC InertSearch InertCap 5MS/EX
LC064 - Analysis of Pioglitazone Hydrochloride and Glimepiride (Under the Condition of the Japanese Pharmacopoeia 18th, Pioglitazone Hydrochloride and Glimepiride Tablets, ASSAY(2)Glimepiride) -

LC InertSearch InertSustainSwift C18
LC063 - Analysis of Pioglitazone Hydrochloride and Glimepiride (Under the Condition of the Japanese Pharmacopoeia 18th, Pioglitazone Hydrochloride and Glimepiride Tablets, ASSAY(1)Pioglitazone Hydrochloride) -

LC InertSearch InertSustainSwift C18
LC060 - Analysis of Aspirin (Under the Condition of the draft for the Japanese Pharmacopoeia 19th, Aspirin Delayed-release Tablets, ASSAY) -

LC InertSearch InertSustain C18
LC059 - Analysis of 1-Fluoro-2,4-dinitrophenyl-5-L-alaninamide (Under the Condition of the draft for the Japanese Pharmacopoeia 19th, Pregabalin, 1-Fluoro-2,4-dinitrophenyl-5-L-alaninamide, Assay) -

LC InertSearch InertSustain AQ-C18
LC057 - Analysis of Methocarbamol (Under the Condition of USP43-NF38, Methocarbamol Tablets, ASSAY) -

LC InertSearch InertSustain C18
LC056 - Analysis of Methocarbamol (Under the Condition of USP43-NF38, Methocarbamol, ASSAY) -

LC InertSearch InertSustain C18
LC055 - Analysis of Dobutamine (Under the Condition of the USPNF 2023 Issue 2, Dobutamine Hydrochloride, ASSAY) -

LC InertSearch Inertsil WP300 C18
LC054 - Analysis of Methocarbamol (Under the Condition of USP43-NF38, Methocarbamol Injection, ASSAY) -

LC InertSearch InertSustain C18
LC048 - Analysis of Homocysteine -

LC InertSearch InertSustain Phenyl
LC047 - Analysis of Homocysteine -

LC InertSearch InertSustain AQ-C18
LC043 - Analysis of Semaglutide and Tirzepatide -

LC InertSearch InertSustainSwift C18
LC040 - Analysis of Acetaminophen (Under the Condition of the USPNF2023 Issue 1, Acetaminophen, IMPURITIES, Limit of Free 4-Aminophenol) -

LC InertSearch InertSustainSwift C8
LC039 - Analysis of Acetaminophen (Under the Condition of the USPNF2023 Issue 1, Acetaminophen, ASSAY) -

LC InertSearch InertSustainSwift C8
LC037 - Analysis of Amlodipine Besilate (Under the Condition of the Japanese Pharmacopoeia 18th, Amlodipine Besilate, Purity(2) Related Substances) -

LC InertSearch InertSustain C18
LC025 - Analysis of Eplerenone (Under the Condition of draft for USP, Eplerenone Tablets, ASSAY) -

LC InertSearch InertSustain AQ-C18
LC024 - Analysis of Eplerenone (Under the Condition of draft for USP, Eplerenone, ASSAY) -

LC InertSearch Inertsil ODS-3
LC023 - Analysis of Lansoprazole (Under the Condition of the USP41-NF36, Lansoprazole Compounded Oral Suspension, ASSAY) -

LC InertSearch InertSustain C18
LC022 - Analysis of Ursodeoxycholic acid (Under the Condition of the Japanese Pharmacopoeia 18th, Ursodeoxycholic acid Tablets, Ursodeoxycholic acid Granules) -

LC InertSearch InertSustain C18
LC019 - Analysis of Aspartame and L-α-Aspartyl-D-phenylalanine Methyl Ester -

LC InertSearch InertSustain C18
LC018 - Analysis of L-α-Aspartyl-D-phenylalanine Methyl Ester (Japan’s Standards and Specifications for Food Additives (10th ed.), Aspartame, Purity(5)) -

LC InertSearch InertSustain C18
LC010 - Analysis of Imazalil (Under the Condition of food additive analysis method in food, Imazalil) -

LC InertSearch Inertsil ODS-3
LC007 - Analysis of Olanzapine -

LC InertSearch InertSustain C8
LC006 - Analysis of Benzoyl Peroxide（Under the Condition of food additive analysis method in food, Benzoyl peroxide) -

LC InertSearch Inertsil ODS-3
LC005 - Carbamazepine -

LC InertSearch InertSustainSwift C18
LC004 - Analysis of Urea and Thiourea -

LC InertSearch InertSustain AQ-C18
LC003 - Analysis of Urea and Thiourea -

LC InertSearch InertSustain Amide
LC002 - Analysis of Phenazopyridine hydrochloride -

LC InertSearch InertSustain C18
LB997 - Analysis of Mesalamine -

LC InertSearch InertSustain C8
LB996 - Analysis of Mesalamine -

LC InertSearch InertSustain C8
LB995 - Analysis of Mesalamine -

LC InertSearch InertSustain C8
LB994 - Analysis of Mesalamine -

LC InertSearch InertSustain C8
LB993 - Analysis of Theophylline -

LC InertSearch InertSustainSwift C8
LB991 - Analysis of Progestrone and Methyltestrone -

LC InertSearch Inertsil WP300 C18
LB990 - Analysis of Xylazine -

LC InertSearch Inertsil WP300 C18
LB989 - Analysis of Xylazine -

LC InertSearch InertSustain C18
LB988 - Analysis of Xylazine -

LC InertSearch InertSustainSwift C8
LB987 - Analysis of Xylazine -

LC InertSearch Inertsil WP300 C18
LB986 - Analysis of Ganciclovir -

LC InertSearch Inertsil ODS-3
LB985 - Analysis of Sumatriptan -

LC InertSearch Inertsil ODS-3
LB984 - Analysis of Sumatriptan -

LC InertSearch InertSustain AQ-C18
LB983 - Analysis of Lornoxicam -

LC InertSearch Inertsil ODS-4
LB982 - Analysis of Ofloxacin -

LC InertSearch InertSustain C18
LB981 - Analysis of Ofloxacin -

LC InertSearch Inertsil WP300 C18
LB980 - Analysis of Desloratadine -

LC InertSearch InertSustain AQ-C18
LB979 - Analysis of Desloratadine -

LC InertSearch InertSustain Cyano
LB978 - Analysis of Hydrochlorothiazide -

LC InertSearch InertSustain AQ-C18
LB964 - Analysis of Citric acid, Tartaric acid, Malic acid, Succinic acid, Lactic acid, Fumaric acid, Acetic acid and their salts -

LC InertSearch InertSphere FA-1
LB963 - Analysis of Citric acid, Tartaric acid, Malic acid, Succinic acid, Lactic acid, Fumaric acid, Acetic acid and their salts -

LC InertSearch InertSphere FA-1
LB961 - Analysis of Lidocaine -

LC InertSearch Insertsil WP300 C18
LB960 - Analysis of Lidocaine -

LC InertSearch Insertsil WP300 C18
LB959 - Analysis of Food Dyes -

LC InertSearch InertSustainSwift C18
LB958 - Analysis of Methyltestosterone and Progesterone -

LC InertSearch Insertsil WP300 C18
LB956 - Analysis of Sumatriptan succinate and Naproxen Sodium -

LC InertSearch Insertsil Ph-3
LB953 - Analysis of Pregabalin (Under the Condition of the draft for the Japanese Pharmacopoeia, Pregabalin Orally Disintegrating Tablets, Pregabalin Capsules) -

LC InertSearch InertSustain Cyano
LB952 - Analysis of Pregabalin (Under the Condition of the draft for the Japanese Pharmacopoeia, Pregabalin Orally Disintegrating Tablets) -

LC InertSearch InertSustain C18
LB951 - Analysis of Pregabalin (Under the Condition of the draft for the Japanese Pharmacopoeia, Pregabalin Capsules) -

LC InertSearch InertSustain C18
LB950 - Analysis of Pregabalin (Under the Condition of the draft for the Japanese Pharmacopoeia, Pregabalin) -

LC InertSearch InertSustain C18
LB948 - Analysis of Omeprazole -

LC InertSearch Inertsil C8-3
LB947 - Analysis of Glacial Acetic Acid -

LC InertSearch InertSustain AQ-C18
LB946 - Analysis of Glacial Acetic Acid -

LC InertSearch InertSustain AQ-C18
LB945 - Analysis of Glacial Acetic Acid -

LC InertSearch InertSustain AQ-C18
LB944 - Analysis of Amikacin sulfate -

LC InertSearch InertSustainSwift C18
LB943 - Analysis of Amikacin -

LC InertSearch InertSustainSwift C18
LB942 - Analysis of Maleic acid -

LC InertSearch Inertsil ODS-4
LB941 - Analysis of Fumaric acid -

LC InertSearch Inertsil ODS-4
LB940 - Analysis of DL-Malic acid -

LC InertSearch InertSustain C18
LB938 - Analysis of Galantamine -

LC InertSearch InertSustain C18
LB937 - Analysis of Febuxostat -

LC InertSearch Inertsil ODS-4
LB936 - Analysis of Febuxostat -

LC InertSearch InertSustain C30
LB935 - Analysis of Febuxostat -

LC InertSearch InertSustain AQ-C18
LB934 - Analysis of Methylpyrazines -

LC InertSearch InertSustain C18
LB933 - Analysis of Diclofenac sodium -

LC InertSearch Inertsil WP300 C18
LB931 - Analysis of Acyclovir -

LC InertSearch Inertsil ODS-3
LB930 - Analysis of Blonanserin -

LC InertSearch InertSustain C18
LB929 - Analysis of Blonanserin -

LC InertSearch InertSustain C18
LB928 - Analysis of Blonanserin -

LC InertSearch InertSustain C18
LB927 - Analysis of Blonanserin -

LC InertSearch InertSustain C18
LB926 - Analysis of Piperacillin Sodium -

LC InertSearch Inertsil WP300 C18
LB925 - Analysis of Acyclovir -

LC InertSearch InertSustain Cyano
LB924 - Analysis of Acyclovir -

LC InertSearch InertSustain Cyano
LB923 - Analysis of Organic acids -

LC InertSearch InertSphere FA-1
LB922 - Analysis of 4 Drugs -

LC InertSearch InertSustai AQ-C18 InertSustain AQ-C18
LB921 - Analysis of 4 Drugs -

LC InertSearch Inertsil ODS-4
LB920 - Analysis of Triphenylphosphine oxide -

LC InertSearch InertSustain C18
LB918 - Analysis of d-α-Tocopheryl Acetate -

LC InertSearch InertSustain C18
LB916 - Analysis of Metformin Hydrochloride -

LC InertSearch InertSustain C18
LB915 - Analysis of Metformin Hydrochloride -

LC InertSearch InertSustain C18
LB914 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18
LB913 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18
LB912 - Analysis of Metformin Hydrochloride -

LC InertSearch Inertsil WP300 C18
LB911 - Analysis of Metformin Hydrochloride -

LC InertSearch Inertsil WP300 C18
LB910 - Analysis of Fatty acids (C18-C26) -

LC InertSearch InertSustain AQ-C18
LB909 - Analysis of Fatty acids (C18-C26) -

LC InertSearch InertSustain AQ-C18
LB908 - Analysis of Fatty acids (C1-C18) -

LC InertSearch InertSustain AQ-C18
LB907 - Analysis of Aripiprazole -

LC InertSearch InertSustain C18
LB906 - Analysis of Aripiprazole -

LC InertSearch InertSustain C18
LB905 - Analysis of Aripiprazole -

LC InertSearch InertSustain C18
LB904 - Analysis of Celecoxib -

LC InertSearch Inertsil Ph-3
LB903 - Analysis of Perospirone hydrochloride -

LC InertSearch InertSustain C18
LB902 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18
LB901 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18
LB900 - Analysis of Fesoterodine Fumarate -

LC InertSearch InertSustain C8
LB899 - Analysis of Fesoterodine Fumarate -

LC InertSearch InertSustainSwift C18
LL042 - Analysis of Ivermectin -

LC InertSearch InertSustain PFP
LB898 - Analysis of Benzoic acid, Sorbic acid and Dehydroacetic acid -

LC InertSearch InertSustain AQ-C18
LB897 - Analysis of Thiamine Hydrochloride -

LC InertSearch Inertsil WP300 C18
LB896 - Analysis of Triptorelin Pamoate -

LC InertSearch InertSustain C18
LB893 - Analysis of PAHs -

LC InertSearch Inertsil ODS-P
LB892 - Analysis of Chlorophenols -

LC InertSearch InertSustain C18 HP
LB891 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18 HP
LB890 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18 HP
LB886 - Analysis of Glyphosate,Mecoprop,Bromacil -

LC InertSearch InertSustain AX-C18
LB885 - Analysis of Voriconazole -

LC InertSearch InertSustain C18
LB884 - Analysis of Voriconazole -

LC InertSearch InertSustain C18
LB883 - Analysis of Paclitaxel -

LC InertSearch InertSustain PFP
LB882 - Analysis of Paracetamol and Mefenamic acid -

LC InertSearch InertSustain C18
LB881 - Analysis of Paracetamol and Mefenamic acid -

LC InertSearch Inertsil ODS-3
LB880 - Analysis of Paracetamol and Mefenamic acid -

LC InertSearch InertSustain C18
LB879 - Analysis of Paracetamol and Mefenamic acid -

LC InertSearch Inertsil ODS-3
LB878 - Analysis of Mefenamic acid -

LC InertSearch InertSustain C18
LB877 - Analysis of Mefenamic acid -

LC InertSearch Inertsil ODS-3
LB876 - Analysis of Cefoxitin -

LC InertSearch InertSustain C18
LB875 - Analysis of Levofloxacin -

LC InertSearch Inertsil ODS-3
LB874 - Analysis of Captopril and Captopril Disulfide -

LC InertSearch InertSustain AQ-C18
LB873 - Tacrolimus Extended-Release Capsules -

LC InertSearch InertSustain AQ-C18
LB872 - Analysis of Febuxostat -

LC InertSearch InertSustain Phenyl
LB871 - Analysis of Febuxostat -

LC InertSearch InertSustain Phenyl
LB870 - Analysis of Febuxostat -

LC InertSearch InertSustain Phenyl
LB869 - L-Ascorbic acid and Erythorbic acid -

LC InertSearch InertSustain Amide
LB868 - Analysis of Propionic Acid -

LC InertSearch InertSustain C18
LB867 - Analysis of Febuxostat -

LC InertSearch InertSustain C18
LB866 - Analysis of Sucralose -

LC InertSearch InertSustain C18
LB865 - Analysis of Water-soluble vitamins and D-Araboascorbic acid -

LC InertSearch InertSustain C18
LB864 - Analysis of Benzoic acid, Sorbic acid and Dehydroacetic acid -

LC InertSearch InertSustain C18
LB863 - Analysis of BHT_BHA_PG（Analytical Method A） -

LC InertSearch InertSustain C18
LB862 - Analysis of Antioxidants -

LC InertSearch InertSustain C18
LB861 - Analysis of L-Ascorbic acid and Erythorbic acid -

LC InertSearch InertSustain NH2
LB860 - Analysis of Glycyrrhizinate acid -

LC InertSearch InertSustain C18
LB859 - Analysis of Amoxicillin and Clavulanate potassium -

LC InertSearch Inertsil ODS-3
LB858 - Analysis of Natamycin (Analytical Method B) -

LC InertSearch InertSustain C18
LB857 - Analysis of Natamycin (Analytical Method A) -

LC InertSearch InertSustain AQ-C18
LB856 - Analysis of Lithium lactylate -

LC InertSearch InertSustain C8
LB855 - Analysis of 6 kinds of Aldehydes (Detected by Pre-Column Method with DNPH) -

LC InertSearch InertSustain C30
LB854 - Analysis of Naringin and Hesperidin -

LC InertSearch InertSustain AQ-C18
LB853 - Analysis of p-Hydroxybenzoic acid esters -

LC InertSearch InertSustain C18
LB852 - Analysis of Benzoic acid -

LC InertSearch InertSustain C18
LB851 - Analysis of Calcium Pantothenate -

LC InertSearch InertSustain AQ-C18
LB850 - Analysis of Ethylenediaminetetraacetic acid ferric sodium salt trihydrate -

LC InertSearch InertSustain C18
LB849 - Analysis of Tolvaptan (Under the Condition of the draft for the Japanese Pharmacopoeia 18th SupplementII) -

LC InertSearch Inertsil ODS-4
LB848 - Analysis of Tolvaptan (Under the Condition of the draft for the Japanese Pharmacopoeia 18th SupplementII) -

LC InertSearch Inertsil ODS-4
LB847 - Analysis of Thiuram -

LC InertSearch InertSustain C30
LB846 - Analysis of Tocopheryl acetate -

LC InertSearch InertSustain C18
LB845 - Analysis of L-Ascorbyl palminate and L-Ascorbic Stearate -

LC InertSearch InertSustain C18
LB844 - Analysis of Malic acid -

LC InertSearch InertSphere FA-1
LB843 - Analysis of Fumaric acid -

LC InertSearch InertSphere FA-1
LB842 - Analysis of Acetic acid -

LC InertSearch InertSphere FA-1
LB841 - Analysis of Lactic acid -

LC InertSearch InertSphere FA-1
LB840 - Analysis of Tartaric acid -

LC InertSearch InertSphere FA-1
LB839 - Analysis of Succinic acid -

LC InertSearch InertSphere FA-1
LB838 - Analysis of Citric acid -

LC InertSearch InertSphere FA-1
LB837 - Analysis of Nonsteroidal anti-inflammatory drug -

LC InertSearch InertSustain C30
LB834 - Analysis of Paraoxybenzoic acid esters -

LC InertSearch InertSustain C18
LB833 - Analysis of Methyl Parahydroxybenzoate -

LC InertSearch InertSustain C18
LB832 - Analysis of Nordihydroguaiaretic Acid -

LC InertSearch InertSustain C18
LB831 - Analysis of Nordihydroguaiaretic Acid -

LC InertSearch InertSustain C18
LB830 - Analysis of Azoxystrobin -

LC InertSearch InertSustain C18
LB829 - Analysis of Sulfamethoxazole and Trimethoprim -

LC InertSearch Inertsil WP300 C18
LB826 - Analysis of Nicotinic acid and Nicotinamide (Under the Condition of food additive analysis method in food) -

LC InertSearch InertSustain C18
LB824 - Analysis of kojic acid -

LC InertSearch InertSustain C18
LB823 - Analysis of Glycyrrhiza -

LC InertSearch Inertsil ODS-3
LB820 - Analysis of ATP related compounds and Cyclic nucleotides (InertSustain C30) -

LC InertSearch InertSustain C30
LB819 - Analysis of ATP and Cyclic nucleotide (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB818 - Analysis of Nucleotides and Cyclic nucleotides -

LC InertSearch InertSustain AX-C18
LB809 - Analysis of ATP related compounds and Guanylic acid -

LC InertSearch InertSustain AQ-C18
LB808 - Analysis of Vitamin D -

LC InertSearch InertSustain C30
LB807 - Analysis of Fat-soluble Vitamins -

LC InertSearch InertSustain C30
LB804 - Analysis of Metformin -

LC InertSearch Inertsil CX
LB801 - Analysis of Chloroacetic acid -

LC InertSearch InertSphere FA-1
LB800 - Analysis of 1,3-Dicyclohexylurea -

LC InertSearch InertSustain C18
LB785 - Analysis of Uric Acid and its related compounds -

LC InertSearch InertSustain AX-C18
LB784 - Analysis of ATP and its related compounds -

LC InertSearch InertSustain AX-C18
LB783 - Analysis of UTP and its related compounds -

LC InertSearch InertSustain AX-C18
LB782 - Analysis of GTP and its related compounds -

LC InertSearch InertSustain AX-C18
LB781 - Analysis of CTP and its related compounds -

LC InertSearch InertSustain AX-C18
LB780 - Analysis of ATP and its related compounds -

LC InertSearch InertSustain AX-C18
LB779 - Analysis of Coenzyme A (CoA) -

LC InertSearch InertSustain AX-C18
LB778 - Analysis of Coenzyme A (CoA) -

LC InertSearch InertSustain AX-C18
LB775 - Analysis of Cyclic Nucleotide -

LC InertSearch InertSustain AX-C18
LB774 - Analysis of Nucleotide sugars -

LC InertSearch InertSustain AX-C18
LB771 - Analysis of Nucleoside and Nucleic acid base -

LC InertSearch InertSustain AX-C18
LB770 - Analysis of Pyruvic acid and Phosphoenolpyruvic acid -

LC InertSearch InertSustain AX-C18
LB769 - Analysis of Thiamine and Thiamine pyrophosphate -

LC InertSearch InertSustain AX-C18
LB768 - Analysis of Low molecular weight Hyaluronic acid -

LC InertSearch InertSustain AX-C18
LB767 - Analysis of Chondroitin Sulfate -

LC InertSearch InertSustain AX-C18
LB766 - Analysis of Glucuronic acid -

LC InertSearch InertSustain AX-C18
LB765 - Analysis of Sialic acid -

LC InertSearch InertSustain AX-C18
LB764 - Analysis of Organic acids -

LC InertSearch InertSustain AX-C18
LB763 - Analysis of Tryptophan metabolites -

LC InertSearch InertSustain AX-C18
LB762 - Analysis of L-Cysteic acid -

LC InertSearch InertSustain AX-C18
LB761 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -

LC InertSearch Inertsil ODS-4
LB760 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -

LC InertSearch InertSustain C18
LB759 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -

LC InertSearch InertSustain AX-C18
LB758 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -

LC InertSearch InertSustain C18
LB757 - Analysis of Fenofibrate (Under the Condition of the Japanese Pharmacopoeia 18th) -

LC InertSearch Inertsil ODS-4
LB756 - Analysis of Fenofibrate (Under the Condition of the Japanese Pharmacopoeia 18th) -

LC InertSearch Inertsil ODS-4
LB755 - Analysis of Oxaliplatin (Under the Condition of the draft for the Japanese Pharmacopoeia18th supplement II) -

LC InertSearch InertSustainSwift C18
LB754 - Analysis of Saccharin (Under the Condition of the Japanese Pharmacopoeia 18th, Saccharin Sodium Hydrate) -

LC InertSearch Inertsil WP300 C18
LB753 - Analysis of Vitamin E -

LC InertSearch InertSustain C30
LB751 - Analysis ofSulfamethoxazole and Trimethoprim -

LC InertSearch Inertsil WP300 C18
LB732 - Analysis of Peptides -

LC InertSearch InertSustain AX-C18
LB731 - Analysis of Peptides -

LC InertSearch InertSustain AX-C18
LB722 - Analysis of Ethenzamide -

LC InertSearch InertSustain C18
LB721 - Analysis of Acetaminophen -

LC InertSearch InertSustain C18
LB720 - Analysis of Acetylsalicilic acid -

LC InertSearch InertSustain C18
LB719 - Analysis of Unsaturated fatty acids -

LC InertSearch InertSustain C30
LB718 - Analysis of Polycyclic Aromatic Hydrocarbons (PAHs) -

LC InertSearch Inertsil ODS-P
LB717 - Analysis of Polycyclic Aromatic Hydrocarbons (PAHs) -

LC InertSearch InertSustain C30
LL041 - Analysis of cannabinoids -

LC InertSearch InertSustain Phenylhexyl HP
LL040 - Analysis of cannabinoids -

LC InertSearch InertSustain Phenylhexyl
LL039 - Analysis of cannabinoids -

LC InertSearch InertSustainSwift C18
LL038 - Analysis of cannabinoids -

LC InertSearch InertSustainSwift C18
LL037 - Analysis of cannabinoids -

LC InertSearch InertSustain C18
LL036 - Analysis of cannabinoids -

LC InertSearch Inertsil ODS-HL HP
LB702 - Analysis of ibuprofen -

LC InertSearch InertSustain C18
LB701 - Analysis of chlorpheniramine maleate -

LC InertSearch Inertsil ODS-4
LB700 - Analysis of acetaminophen -

LC InertSearch InertSustain C18
LB696 - Analysis of Trifluoroacetic acid -

LC InertSearch InertSustain AQ-C18
LB695 - Analysis of acetic acid （USP） -

LC InertSearch InertSustainSwift C18
LB690 - Analysis of Nitrosamines -

LC InertSearch InertSustain PFP
LB686 - Analysis of Chlorogenic acid -

LC InertSearch InertSustain AX-C18
LB684 - Analysis of Saccharin Sodium Hydrate -

LC InertSearch Inertsil WP300 C18
LB683 - Analysis of Saccharin -

LC InertSearch Inertsil WP300 C18
LB682 - Analysis of Acetic acid and Acetic anhydride -

LC InertSearch InertSustainSwift C18
LB681 - Analysis of Moxifloxacin -

LC InertSearch InertSustain Phenylhexyl
LB677 - Analysis of Zebularine and Gemcitabine -

LC InertSearch InertSustain C18 HP
LB676 - Analysis of Anticancer drug and related substances -

LC InertSearch InertSustain PFP HP
LB673 - Analysis of Limonene -

LC InertSearch InertSustain C18
LB672 - Analysis of Stearyl Glycyrrhetinate -

LC InertSearch InertSustainSwift C8
LB669 - Analysis of Rosuvastatin calcium (Under the condition of the Japanese Pharmacopoeia (JP) ) -

LC InertSearch InertSustainSwift C18
LB668 - Analysis of Nitrosoamines (NDMA, NDEA) -

LC InertSearch InertSustain PFP
LB667 - Analysis of Ribonuclease A -

LC InertSearch MonoSelect RP-mAb
LB666 - Analysis of Myoglobin -

LC InertSearch MonoSelect RP-mAb
LB665 - Analysis of Lysozyme -

LC InertSearch MonoSelect RP-mAb
LB664 - Analysis of Insulin -

LC InertSearch MonoSelect RP-mAb
LB663 - Analysis of IgG -

LC InertSearch MonoSelect RP-mAb
LB662 - Analysis of HSA -

LC InertSearch MonoSelect RP-mAb
LB661 - Analysis of BSA -

LC InertSearch MonoSelect RP-mAb
LB660 - Analysis of Copovidone(Under the Condition of European Pharmacopoeia 10.0, Impurity A) -

LC InertSearch Inertsil ODS-4
LB659 - Analysis of Tamsulosin hydrochloride (Under the Condition of the Japanese harmacopoeia) -

LC InertSearch Inertsil ODS-HL
LB658 - Analysis of Tamsulosin hydrochloride (Under the Condition of the Japanese harmacopoeia) -

LC InertSearch Inertsil ODS-HL
LB657 - Analysis of Peptides -

LC InertSearch InertSustain PFP
LB656 - Analysis of Peptides -

LC InertSearch InertSustain AQ-C18
LB655 - Analysis of Peptides -

LC InertSearch InertSustain C18
LB654 - Analysis of Peptides -

LC InertSearch InertSustain Amide
LB653 - Analysis of Oligonucleotides -

LC InertSearch InertSustain Amide
LB652 - Analysis of UTP and its related compounds -

LC InertSearch InertSustain Amide
LB651 - Analysis of GTP and its related compounds -

LC InertSearch InertSustain Amide
LB650 - Analysis of CTP and its related compounds -

LC InertSearch InertSustain Amide
LB649 - Analysis of ATP and its related compounds -

LC InertSearch InertSustain Amide
LB648 - Analysis of Nucleotide sugars -

LC InertSearch InertSustain Amide
LB647 - Analysis of Nicotinamide Adenine Dinucleotide (NADH, NAD+) -

LC InertSearch InertSustain Amide
LB646 - Analysis of Nucleobase and Nucleosides -

LC InertSearch InertSustain Amide
LB645 - Analysis of Glyphosate and Glufosinate -

LC InertSearch InertSustain Amide
LB644 - Analysis of Methylhippuric acids -

LC InertSearch InertSustain Amide
LB643 - Analysis of Dipeptides -

LC InertSearch InertSustain Amide
LB641 - Analysis of Rosuvastatin Calcium (Under the Condition of draft for Japanese Pharmacopoeia, Rosuvastatin Calcium) -

LC InertSearch InertSustain C18
LB640 - Analysis of Rosuvastatin Calcium (Under the Condition of draft for Japanese Pharmacopoeia, Rosuvastatin Calcium) -

LC InertSearch InertSustain C18
LL032 - Analysis of Abraxane -

LC InertSearch MonoSelect nPEC
LB639 - Analysis of Levetiracetam (Under the Condition of USP42-NF37 1S, Levetiracetam Oral Solution) -

LC InertSearch InertSustainSwift C18
LB638 - Analysis of Levetiracetam (Under the Condition of USP42-NF37 1S, Levetiracetam Oral Solution) -

LC InertSearch InertSustain C18
LB637 - Analysis of Levetiracetam (Under the Condition of USP42-NF37 1S, Levetiracetam Extended-Release Tablets) -

LC InertSearch InertSustain C8
LB636 - Analysis of Levetiracetam (Under the Condition of USP42-NF37 1S, Levetiracetam Tablets) -

LC InertSearch InertSustainSwift C18
LB635 - Analysis of Levetiracetam (Under the Condition of draft for USP) -

LC InertSearch InertSustain AQ-C18 HP
LB634 - Analysis of Rivaroxaban (Under the Condition of draft for USP, Rivaroxaban Tablets) -

LC InertSearch InertSustainSwift C18
LB633 - Analysis of Rivaroxaban (Under the Condition of draft for USP) -

LC InertSearch InertSustainSwift C18
LB632 - Analysis of Telmisartan and Amlodipine besilate (Under the Condition of Japanese Pharmacopoeia, Telmisartan and Amlodipine Besilate Tablets) -

LC InertSearch Inertsil C8-3
LB631 - Analysis of Telmisartan and Amlodipine besilate (Under the Condition of Japanese Pharmacopoeia, Telmisartan and Amlodipine Besilate Tablets) -

LC InertSearch Inertsil C8-3
LB630 - Analysis of Amlodipine besilate (Under the Condition of Japanese Pharmacopoeia, Telmisartan and Amlodipine Besilate Tablets) -

LC InertSearch Inertsil C8-3
LB629 - Analysis of Telmisartan (Under the Condition of Japanese Pharmacopoeia, Telmisartan and Amlodipine Besilate Tablets) -

LC InertSearch Inertsil C8-3
LB628 - Analysis of Copovidone (Under the Condition of the draft for the Japanese Pharmacopoeia, (7) 2-Pyrrolidone) -

LC InertSearch Inertsil ODS-3
LB627 - Analysis of Copovidone (Under the Condition of the draft for the Japanese Pharmacopoeia, (4) 1-Vinyl-2-pyrrolidone and vinyl acetate) -

LC InertSearch Inertsil ODS-4
LB626 - Analysis of Prasugrel hydrochloride -

LC InertSearch InertSustain C18
LB625 - Analysis of Prasugrel hydrochloride (Under the Condition of USP42-NF37) -

LC InertSearch InertSustainSwift C18
LB624 - Analysis of Etoposide phosphate (Under the Condition of draft for USP) -

LC InertSearch InertSustain Phenyl
LB623 - Analysis of Etoposide phosphate (Under the Condition of draft for USP) -

LC InertSearch InertSustain Phenyl
LB622 - Analysis of Venlafaxine hydrochloride (Under the Condition of USP41-NF36, Venlafaxine Hydrochloride Extended-Release Capsules) -

LC InertSearch InertSustain C18
LB621 - Analysis of Venlafaxine hydrochloride (Under the Condition of USP41-NF36, Venlafaxine Hydrochloride Extended-Release Capsules) -

LC InertSearch InertSustain C18
LB620 - Analysis of Venlafaxine hydrochloride (Under the Condition of USP41-NF36, Venlafaxine Tablets) -

LC InertSearch InertSustain C18
LB619 - Analysis of Venlafaxine hydrochloride (Under the Condition of USP41-NF36, Venlafaxine Hydrochloride) -

LC InertSearch InertSustain C8
LB618 - Analysis of Pregabalin (Under the Condition of USP41-NF36, Pregabalin) -

LC InertSearch Inertsil ODS-3
LB617 - Analysis of Levocetirizine -

LC InertSearch Inertsil SIL-100A
LB616 - Analysis of Levocetirizine (Under the Condition of USP41-NF36, Levocetirizine Dihydrochloride) -

LC InertSearch Inertsil SIL-100A
LB615 - Analysis of Cromolyn (Under the Condition of USP41-NF36, Cromolyn Sodium) -

LC InertSearch InertSustain C18
LB614 - Analysis of L-Ascorbic acid 2-glucoside -

LC InertSearch Inertsil ODS-HL
LB613 - Analysis of Isopropylmethylphenol -

LC InertSearch InertSustain AQ-C18
LB612 - Analysis of Tetracaine -

LC InertSearch InertSustain Cyano
LB611 - Analysis of Sertraline -

LC InertSearch InertSustain Cyano
LB610 - Analysis of Nortriptyline -

LC InertSearch InertSustain Cyano
LB609 - Analysis of Chlorophenols -

LC InertSearch InertSustain Cyano
LB608 - Analysis of Citral -

LC InertSearch InertSustain Cyano
LB607 - Analysis of Plant hormones -

LC InertSearch InertSustain Cyano
LB606 - Analysis of Antihistamines -

LC InertSearch InertSustain Cyano HP
LB605 - Analysis of Antihistamines -

LC InertSearch InertSustain Cyano HP
LB604 - Analysis of Antidepressants -

LC InertSearch InertSustain Cyano HP
LB603 - Analysis of Steroids -

LC InertSearch InertSustain Cyano HP
LB602 - Analysis of Methylhippuric acids -

LC InertSearch InertSustain Cyano HP
LB601 - Analysis of Proteins -

LC InertSearch MonoSelect C18 for HTS
LB599 - Analysis of Hydroquinone, Resorcinol, and Catechol -

LC InertSearch MonoSelect C18 for HTS
LB598 - Analysis of Acephate and Methamidophos -

LC InertSearch MonoSelect C18 for HTS
LB594 - Analysis of Estrogen -

LC InertSearch InertSustain PFP
LB593 - Analysis of Steroids -

LC InertSearch InertSustain PFP
LB591 - Analysis of Antihistamines -

LC InertSearch InertSustain PFP
LB590 - Analysis of Antihistamines -

LC InertSearch InertSustain PFP
LB589 - Analysis of β-blockers -

LC InertSearch InertSustain PFP
LB588 - Analysis of Antidepressants -

LC InertSearch InertSustain PFP
LB587 - Analysis of Eugenol -

LC InertSearch InertSustain PFP
LB586 - Analysis of Sterols -

LC InertSearch InertSustain PFP
LB585 - Analysis of Unsaturated fatty acids -

LC InertSearch InertSustain PFP
LB584 - Analysis of Melamine and its related compounds -

LC InertSearch InertSustain PFP
LB580 - Analysis of Urea, Ornithine, and Arginine -

LC InertSearch InertSustain PFP
LB579 - Analysis of Lysine, Methionine, and Carnitine -

LC InertSearch InertSustain PFP
LB578 - Analysis of Cysteine and its related compounds -

LC InertSearch InertSustain PFP
LB577 - Analysis of Glutathione -

LC InertSearch InertSustain PFP
LB576 - Analysis of Uric Acid and its related compounds -

LC InertSearch InertSustain PFP
LB575 - Analysis of Tryptophan and its related compounds -

LC InertSearch InertSustain PFP
LB574 - Analysis of Catecholamines -

LC InertSearch InertSustain PFP
LB573 - Analysis of Dipeptides -

LC InertSearch InertSustain PFP
LB572 - Analysis of Nucleosides -

LC InertSearch InertSustain PFP
LB571 - Analysis of Nicotinamide Adenine Dinucleotide (NADH, NAD+) -

LC InertSearch InertSustain PFP
LT170 - Analysis of Vitamins D2 and D3 in Foods -

LC Technical Note Inertsil Diol Inertsil ODS-P
LT169 - Vitamin B12 Analysis in Foods by HPLC -

LC Technical Note Inertsil Diol Inertsil WP300 Diol Inertsil ODS-4
LT166 - Simultaneous Analysis of 12 Soybean Isoflavones -

LC Technical Note InertSustainSwift C18
LT163 - Analysis of UV Absorbers in Cosmetic Products -

LC Technical Note InertSustain C18
LT161 - Purification of Ribavirin in Human Serum Using MonoSpin PBA -

LC Technical Note InertSustain AQ‐C18 HP
LT159 - Assay Test for Esomeprazole Magnesium Delayed -Release Capsules under USP Method -

LC Technical Note InertSustain C18
LT157 - Examination of Loading Capacity of Proteins Using MonoSpin C18 -

LC Technical Note InertSustainBio C18
LT156 - Sample Preparation of Peptides and Proteins Using MonoSpin C18 -Obtain High Recovery with Ethanol Elution- -

LC Technical Note InertSustainBio C18
LT134 - How to Use Preparative HPLC - Part 2 (Scaling Up from Analytical HPLC) -

LC Technical Note Inertsil ODS-3
LT133 - How to Use Preparative HPLC - Part 1 Evaluation of loading amount -

LC Technical Note
LT132 - Simultaneous Analysis of Cyanoguanidine and Melamine in Food by LC/MS/MS -

LC Technical Note
LT124 - Analysis of Furfural in Insulating Oil -

LC Technical Note InertSustainSwift C18 InertSustain AQ-C18
LT105 - Selective Isolation of Phosphopeptides -

LC Technical Note
LT104 - Analysis of Paraquat and Diquat in Urine -

LC Technical Note Inertsil ODS-3
LT099 - Analysis of Valsartan -

LC Technical Note InertSustain C18
LT098 - Analysis of Amlodipine -

LC Technical Note Inertsil ODS-4 HP
LT097 - Analysis of Pioglitazone Hydrocloride -

LC Technical Note Inertsil ODS-4 HP
LT096 - Analysis of Atorvastatin Calcium -

LC Technical Note Inertsil C8-4 Inertsil C8-4 HP
LT094 - Analysis of Preservatives in Foods -Third Report- -

LC Technical Note Inertsil ODS-4
LT092 - Analysis of Tranexamic Acid According to the Japanese Pharmacopoeia -

LC Technical Note InertSustain AQ-C18 Inertsil ODS-4
LT090 - Analysis of Uric Acid in Serum -

LC Technical Note Inertsil ODS-4
LT089 - Analysis of Rosmarinic Acid in Perilla Juice -

LC Technical Note Inertsil ODS-4
LT088 - Analysis of Curcumin in Nutrient Drinks -

LC Technical Note Inertsil ODS-4
LT084 - Analysis of Hippuric Acid in Urine by HPLC -

LC Technical Note Inertsil ODS-80A
LT081 - Analysis of Synthetic Sweeteners in Foods -Acesulfame Potassium, Saccharin Sodium, Aspartame- -

LC Technical Note Inertsil ODS-4
LT080 - Analysis of Sennosides in Senna in Accordance with the Japanese Pharmacopoeia -

LC Technical Note Inertsil ODS-4
LT076 - Analysis of Preservatives in Foods - Second Report -

LC Technical Note Inertsil ODS-3
LT075 - HPLC Analysis of Preservatives in Foods -

LC Technical Note Inertsil ODS-3
LT074 - Analysis of Niacin in Foods -

LC Technical Note Inertsil ODS-3
LT073 - Analysis of Lycopene in Food by HPLC -

LC Technical Note Inertsil ODS-3
LT070 - Analysis of Furfurals in Foods -

LC Technical Note Inertsil ODS-3
LT069 - Analysis of Diosgenin in Foods -

LC Technical Note Inertsil ODS-SP
LT065 - Analysis of Phenolic Antioxidants in Food by HPLC (2) -

LC Technical Note Inertsil ODS-SP Inertsil Ph-3
LT064 - Analysis of Phenolic Antioxidants in Food by HPLC (1) -

LC Technical Note Inertsil ODS-SP
LT063 - Analysis of Tert Butylhydroquinone (TBHQ) in Foods by HPLC -

LC Technical Note Inertsil ODS-SP
LT061 - Analysis of Polyphenol in Food by HPLC -

LC Technical Note Inertsil ODS-3
LT054 - Analysis of Betaine, myo-Inositol and N-acetyl-D-glucosamine in Food, -

LC Technical Note Inertsil NH2
LT052 - Analysis of Geniposide with a Photodiode Array Detection -

LC Technical Note Inertsil ODS-SP
LT051 - Analysis of Allantoin in Cosmetics Using HILIC HPLC -

LC Technical Note Inertsil HILIC
LT045 - Analysis of Water-soluble Vitamins by HPLC-ECD -

LC Technical Note Inertsil ODS-SP Inertsil ODS-3
LT044 - Analysis of Bufosteroids in Senso In Accordance with the Japanese Pharmacopoeia -

LC Technical Note Inertsil ODS-P
LT040 - Analysis of peony (Chinese paeoniflorin) in accordance with the 15th edition of the Japanese Pharmacopoeia -

LC Technical Note Inertsil ODS-3 Inertsil ODS-SP
LT039 - Analysis of Glycyrrhizic Acid in Licorice According to the Japanese Pharmacopoeia -

LC Technical Note
LT038 - Analysis of Scopolamine and Hyoscyamine in Scopolia Extract in Accordance with the Japanese Pharmacopoeia -

LC Technical Note Inertsil ODS-SP
LT034 - Analysis of Vitamin E in Food by HPLC -

LC Technical Note Inertsil NH2
LT033 - Isolation of Vitamin D2 and D3 in Foods by HPLC -

LC Technical Note Inertsil NH2 Inertsil ODS-P
LT023 - Analysis of Catechins in Soft Drink -

LC Technical Note Inertsil ODS-3
LT022 - Introduction to an Aldehyde Analyzer -

LC Technical Note Inertsil ODS-80A
LT021 - Analysis of Coenzyme Q10 in Supplements and Cosmetics -

LC Technical Note Inertsil ODS-3
LT020 - Analysis of L-Carnitine in Supplements and Energy Drinks -

LC Technical Note Inertsil ODS-3
LT019 - Analysis of α-Lipoic Acid in Supplements and Cosmetics -

LC Technical Note Inertsil ODS-3
LT009 - Analysis of Vitamin C in Food by HPLC -

LC Technical Note Inertsil SIL-100A Inertsil NH2
LT005 - Analysis of Fungicides in Citrus Fruits -

LC Technical Note Inertsil ODS-3
LT002 - Analysis of Colorants by HPLC-PDA -

LC Technical Note Inertsil ODS-3
LL031 - Analysis of Coumaric acid and Ferulic acid -

LC InertSearch Inertsil ODS-HL
LL027 - Analysis of Isothiazolinone preservatives -

LC InertSearch InertSustain AQ-C18
LL025 - Analysis of PEGylated liposome -

LC InertSearch Inertsil WP300 Diol
LL023 - Analysis of Triclosan -

LC InertSearch InertSustain C18
LL022 - Analysis of Catechins (InertSustain C18) -

LC InertSearch InertSustain C18
LL021 - Analysis of Catechins (InertSustain Phenylhexyl) -

LC InertSearch InertSustain Phenylhexyl
LL020 - Analysis of Catechins (InertSustain Phenyl) -

LC InertSearch InertSustain Phenyｌ
LL019 - Analysis of Food Colorants (InertSustainSwift C18) -

LC InertSearch InertSustainSwift C18
LL018 - Analysis of Food Colorants (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LL017 - Analysis of Food Colorants (InertSustain C18) -

LC InertSearch InertSustain C18
LL016 - Analysis of Food Colorants (InertSustain Phenylhexyl) -

LC InertSearch InertSustain Phenylhexyl
LL015 - Simultaneous analysis of metabolites using LCMSMS (5) - compounds related to central metabolism part 2 - -

LC InertSearch InertSustain C18
LL014 - Simultaneous analysis of metabolites using LCMSMS (4) - compounds related to central metabolism part 1 - -

LC InertSearch InertSustain C18
LL009 - Analysis of Dipeptide type sweetners -

LC InertSearch Inertsil ODS-4
LL005 - Study of the Behavior of Water-Soluble Vitamins in HILIC on a Diol Column -

LC InertSearch Inertsil HILIC
LL003 - A Non-hazardous Technique to Determine Penicillin G and Penicillin G Procaine in Beef -

LC InertSearch Inertsil WP300 C4
LB570 - Analysis of Steviol glycosides (Under the Condition of the JSFA-VIII (Japanese Standards of Food Additives), Stevia Extract) -

LC InertSearch Inertsil NH2
LB569 - Analysis of Steviol glycosides (Under the Condition of the JSFA-VIII (Japanese Standards of Food Additives), Stevia Extract) -

LC InertSearch InertSustain NH2
LB568 - Analysis of Steviol glycosides (Under the Condition of the JSFA-IX (Japanese Standards of Food Additives), Steviol Glycosides) -

LC InertSearch InertSustain AQ-C18
LB567 - Analysis of Steviol glycosides (Under the Condition of the JSFA-IX (Japanese Standards of Food Additives), Steviol Glycosides) -

LC InertSearch Inertsil ODS-HL
LB566 - Analysis of Steviol glycosides (Under the Condition of the JSFA-IX (Japanese Standards of Food Additives), Stevia Extract) -

LC InertSearch InertSustain AQ-C18
LB565 - Analysis of Steviol glycosides (Under the Condition of the JSFA-IX (Japanese Standards of Food Additives), Stevia Extract) -

LC InertSearch Inertsil ODS-HL
LB564 - Analysis of Steviol glycosides (Under the Condition of the JPE (Japanese Pharmaceutical Excipients), Purified Stevia Extract Assay) -

LC InertSearch Inertsil NH2
LB563 - Analysis of Steviol (Under the Condition of the JPE (Japanese Pharmaceutical Excipients), Purified Stevia Extract (4) Steviol) -

LC InertSearch InertSustain AQ-C18
LB562 - Analysis of Steviol (Under the Condition of the JPE (Japanese Pharmaceutical Excipients), Purified Stevia Extract (4) Steviol) -

LC InertSearch Inertsil ODS-HL
LB561 - Analysis of Neotame (Under the Condition of the JSFA-IX (Japanese Standards of Food Additives)) -

LC InertSearch InertSustain AQ-C18
LB560 - Analysis of Advantame (Under the Condition of the JSFA-IX (Japanese Standards of Food Additives)) -

LC InertSearch InertSustain AQ-C18
LB559 - Analysis of Artificial sweeteners -

LC InertSearch InertSustain AQ-C18
LB558 - Analysis of 16 Aldehyde (Detected by Pre-Column Method with DNPH) -

LC InertSearch InertSustain PFP
LB557 - Analysis of 16 Aldehyde (Detected by Pre-Column Method with DNPH) -

LC InertSearch InertSustain PFP
LB556 - Analysis of Mirtazapine -

LC InertSearch InertSustain C18
LB555 - Analysis of Mirtazapine (Under the Condition of draft for USP, Mirtazapine Compounded Oral Suspension, Veterinary) -

LC InertSearch Inertsil ODS-3
LB554 - Analysis of Mirtazapine (Under the Condition of USP41-NF36, Mirtazapine Orally Disintegrating Tablets) -

LC InertSearch InertSustainSwift C18
LB553 - Analysis of Mirtazapine (Under the Condition of USP41-NF36, Mirtazapine Tablets) -

LC InertSearch InertSustain C18
LB552 - Analysis of Mirtazapine (Under the Condition of USP41-NF36, Mirtazapine) -

LC InertSearch InertSustain C18
LB551 - Analysis of Ezetimibe (Under the Condition of USP41-NF36, Ezetimibe Tablets) -

LC InertSearch InertSustainSwift C18
LB550 - Analysis of Ezetimibe (Under the Condition of USP41-NF36, Ezetimibe Tablets) -

LC InertSearch InertSustainSwift C18
LB549 - Analysis of Ezetimibe (Under the Condition of USP41-NF36, Ezetimibe) -

LC InertSearch InertSustain PFP
LB548 - Analysis of Sitagliptin (Under the Condition of draft for USP, Sitagliptin and Metformin Hydrochloride Tablets) -

LC InertSearch InertSustain C18
LB547 - Analysis of Sitagliptin (Under the Condition of draft for USP, Sitagliptin and Metformin Hydrochloride Tablets) -

LC InertSearch InertSustain C18
LB546 - Analysis of Cinacalcet Hydrochloride (Under the Condition of draft for USP) -

LC InertSearch InertSustainSwift C18
LB545 - Analysis of Cinacalcet Hydrochloride (Under the Condition of draft for USP) -

LC InertSearch InertSustainSwift C18
LB541 - Analysis of 6 kinds of Aldehydes Specified in Japanese Offensive Odor Control Law (Detected by Pre-Column Method with DNPH) -

LC InertSearch Inertsil C8-4
LB540 - Analysis of 6 kinds of Aldehydes Specified in Japanese Offensive Odor Control Law (Detected by Pre-Column Method with DNPH) -

LC InertSearch InertSustain PFP
LB539 - Analysis of 6 kinds of Aldehydes Specified in Japanese Offensive Odor Control Law (Detected by Pre-Column Method with DNPH) -

LC InertSearch InertSustain PFP
LB538 - Analysis of Organic acid -

LC InertSearch SYPRON AX-2
LB536 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of USP41-NF36, Telmisartan and Hydrochlorothiazide Tablets) -

LC InertSearch InertSustain C18
LB535 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of USP41-NF36, Telmisartan and Hydrochlorothiazide Tablets) -

LC InertSearch InertSustainSwift C8
LB534 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of USP41-NF36, Telmisartan and Hydrochlorothiazide Tablets) -

LC InertSearch InertSustain C8
LB533 - Analysis of Dexamathasone Sodium Phosphate (Under the Condition of USP41-NF36, Dexamathasone Sodium Phosphate) -

LC InertSearch Inertsil ODS-3
LB532 - Analysis of Sodium Valproate (Under the Condition of the draft for the Japanese Pharmacopoeia, Sodium Valproate Extended-release Tablets B) -

LC InertSearch InertSustain C18
LB531 - Analysis of Sodium Valproate (Under the Condition of the draft for the Japanese Pharmacopoeia, Sodium Valproate Extended-release Tablets A) -

LC InertSearch InertSustain C18
LB529 - Analysis of Carnosine (Under the Condition of the draft for the Japanese Pharmacopoeia, Poraprezinc Granules) -

LC InertSearch InertSustain C18
LB528 - Analysis of Carnosine (Under the Condition of the draft for the Japanese Pharmacopoeia, Poraprezinc) -

LC InertSearch InertSustain C18
LB527 - Analysis of Dexamathasone Sodium Phosphate (Under the Condition of the draft for the Japanese Pharmacopoeia, Dexamathasone Sodium Phosphate) -

LC InertSearch Inertsil ODS-4
LB526 - Analysis of Dexamathasone Sodium Phosphate (Under the Condition of the draft for the Japanese Pharmacopoeia, Dexamathasone Sodium Phosphate) -

LC InertSearch Inertsil ODS-4
LB525 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of the draft for the Japanese Pharmacopoeia, Telmisartan and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil C8-3
LB524 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of the Japanese Pharmacopoeia supplement II, Telmisartan and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil C8-3
LB523 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of the draft for the Japanese Pharmacopoeia, Telmisartan and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil C8-3
LB521 - Analysis of Folic acid -

LC InertSearch InertSustain C18
LB520 - Analysis of Valsartan and Hydrochlorothiazide(Under the Condition of the draft for the Japanese Pharmacopoeia, Valsartan and Hydrochlorothiazide Tablets) -

LC InertSearch InertSustain C18
LB519 - Analysis of Valsartan and Hydrochlorothiazide(Under the Condition of the draft for the Japanese Pharmacopoeia, Valsartan and Hydrochlorothiazide Tablets) -

LC InertSearch InertSustainSwift C18
LB518 - Analysis of Glycyrrhetinic acid (Under the Condition of the Japanese Standards of Quasi-drug Ingredients, Monoammonium α-Glycyrrhizinate) -

LC InertSearch InertSustain C18
LB517 - Analysis of Glycyrrhizic acid (Under the Condition of the Japanese Standards of Quasi-drug Ingredients, Glycyrrhiza Extracted Powder) -

LC InertSearch InertSustain C18
LB516 - (Under the Condition of the Japanese Standards of Quasi-drug Ingredients, Coffee Extract) -

LC InertSearch InertSustain C18
LB515 - Analysis of Caffeine (Under the Condition of the Japanese Standards of Quasi-drug Ingredients, Coffee Extract) -

LC InertSearch InertSustain C18
LB514 - Analysis of Oligonucleotides -

LC InertSearch InertSustainSwift C18
LB512 - Analysis of Pioglitazone hydrochloride （Under the Condition of the draft for USP） -

LC InertSearch InertSustain C18
LB511 - Analysis of Parabens, Estradiol and Progesterone -

LC InertSearch InertSustainSwift C18
LB510 - Analysis of Estradiol and Progesterone (Under the Condition of the draft for the Japanese Standards of Quasi-drug Ingredients, Placental Extract) -

LC InertSearch InertSustainSwift C18
LB508 - Analysis of Sitagliptin (Under the Condition of the draft for the Japanese Pharmacopoeia, Sitagliptin Phosphate Hydrate) -

LC InertSearch InertSustain Cyano
LB503 - Analysis of Warfarin Potassium (Under the Condition of the Japanese Pharmacopoeia 17th edition, (3) Related subatances) -

LC InertSearch InertSustain Cyano
LB502 - Analysis of Warfarin Potassium (Under the Condition of the Japanese Pharmacopoeia 17th edition) -

LC InertSearch InertSustain Cyano
LB500 - Analysis of Melamine related compounds -

LC InertSearch InertSustain Amide
LB499 - Analysis of Purine bases -

LC InertSearch InertSustain Amide
LB498 - Analysis of Analysis of Tasty Components -

LC InertSearch InertSustain Amide
LB497 - Analysis of Amino acids -

LC InertSearch InertSustain Amide
LB495 - Analysis of Tyramine and Histamine -

LC InertSearch InertSustain Amide
LB494 - Analysis of Corticosteroids -

LC InertSearch Inertsil ODS-HL
LB493 - Analysis of Tryptophan metabolites -

LC InertSearch InertSustain Amide
LB491 - Analysis of Nucleobases -

LC InertSearch InertSustain Amide
LB490 - Analysis of Nucleosides -

LC InertSearch InertSustain Amide
LB489 - Analysis of Azosemide (Under the Condition of the draft for the Japanese Pharmacopoeia, Azosemide Tablets) -

LC InertSearch InertSustain C18
LB487 - Analysis of Verapamil Hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Verapamil Hydrochloride Tablets) -

LC InertSearch InertSustain C18
LB486 - Analysis of Clomipramine Hydorochloride (Under the Condition of the Japanese Pharmacopoeia, Clomipramine Hydorochloride Tablets) -

LC InertSearch Inertsil ODS-3
LB485 - Analysis of Pyridoxal Phosphate Hydrate (Under the Condition of the Japanese Pharmacopoeia, (4) Related subatances) -

LC InertSearch InertSustain AQ-C18
LB483 - Analysis of Minocycline Hydrochloride (Under the Condition of the Japanese Pharmacopoeia 17th edition) -

LC InertSearch InertSustainSwift C8
LB482 - Analysis of Glycyrrhiza (Under the Condition of the Japanese Pharmacopoeia 17th edition) -

LC InertSearch Inertsil ODS-4
LB480 - Analysis of 13 kinds of Aldehydes (Directed by Pre-Column Method with DNPH) -

LC InertSearch InertSustain C18
LB477 - Analysis of Povidone(Under the Condition of the Japanese Pharmacopoeia 17th edition, (7) Formic acid) -

LC InertSearch InertSphere FA-1
LB476 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

LC InertSearch Inertsil Ph
LB475 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

LC InertSearch Inertsil Ph-3
LB474 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

LC InertSearch InertSustain Phenylhexyl
LB473 - Analysis of Solifenacin Succinate (Under the Condition of the draft for USP) -

LC InertSearch InertSustain Phenyl
LB472 - Analysis of Tramadol Hydrochloride (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch InertSustainSwift C8
LB471 - Analysis of Tramadol Hydrochloride (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C8
LB469 - Analysis of Vitamin K（Inertsil ODS-HL） -

LC InertSearch Inertsil ODS-HL
LB468 - Analysis of Vitamin K（InertSustainSwift C8） -

LC InertSearch InertSustainSwift C8
LB467 - Analysis of Vitamin D -

LC InertSearch Inertsil ODS-HL
LB466 - Analysis of Oxalic acid -

LC InertSearch InertSustain Amide
LB465 - Analysis of Fungicides -

LC InertSearch InertSustain C18
LB464 - Analysis of Ultraviolet absorbers -

LC InertSearch InertSustain C18
LB463 - Analysis of Ibuprofen (Under the Condition of USP 39-NF34, Ibuprofen Oral Suspension) -

LC InertSearch InertSustain C8
LB462 - Analysis of Cephalexin (Under the Condition of USP 39-NF34) -

LC InertSearch InertSustain C18
LB461 - Analysis of Phenylephrine Hydrochloride (Under the Condition of USP 39-NF34, Phenylephrine Hydrochloride Injection) -

LC InertSearch InertSustain C18
LB460 - Analysis of Estradiol (Under the Condition of USP 39-NF34) -

LC InertSearch Inertsil ODS-3
LB459 - Analysis of Acetaminophen (Under the Condition of USP 39-NF34, Acetaminophen Capsules) -

LC InertSearch Inertsil ODS-3
LB458 - Analysis of Glyburide (Under the Condition of USP 39-NF34) -

LC InertSearch Inertsil C8
LB457 - Analysis of Hydroxynaphthoquinones -

LC InertSearch InertSustain C18
LB456 - Analysis of Benzenediols -

LC InertSearch InertSustain C18
LB453 - Analysis of Tranexamic acid(Under the Condition of the Japanese Pharmacopoeia, Tranexamic acid Capsules) -

LC InertSearch Inertsil ODS-4
LB452 - Analysis of Tranexamic acid(Under the Condition of the Japanese Pharmacopoeia, Tranexamic acid Tablets) -

LC InertSearch InertSustain AQ-C18
LB451 - Analysis of Tranexamic acid(Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain AQ-C18
LB450 - Analysis of Tranexamic acid(Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain AQ-C18
LB449 - Analysis of Lansoprazole(Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB448 - Analysis of Mesalazine(Under the Condition of the draft for the Japanese Pharmacopoeia, (8) 3-Aminophenol, 3-Aminobenzoic acid, Gentisic acid, Salicylic acid, other related substances and total related substance) -

LC InertSearch InertSustain C8
LB447 - Analysis of Mesalazine(Under the Condition of the draft for the Japanese Pharmacopoeia, (6) 2-Aminophenol and 4-Aminophenol) -

LC InertSearch InertSustainSwift C18 HP
LB446 - Analysis of Hydrocortisone butyrate(Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-3 HP
LB445 - Analysis of Pazufloxacin mesilate (Under the Condition of the Japanese Pharmacopoeia 18th edition) -

LC InertSearch Inertsil ODS-3
LB444 - Analysis of Pazufloxacin mesilate(Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-2
LB443 - Analysis of Nucleotide -

LC InertSearch InertSustain AQ-C18
LB442 - Analysis of Aflatoxin M1(Inertsil ODS-3) -

LC InertSearch Inertsil ODS-3
LB441 - Analysis of Aflatoxin M1(InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB440 - Analysis of Myoglobin Digests (InertSustainSwift C18) -

LC InertSearch InertSustainSwift C18
LB439 - Analysis of Myoglobin Digests (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB438 - Analysis of BSA Digests (InertSustainSwift C18) -

LC InertSearch InertSustainSwift C18
LB437 - Analysis of BSA Digests (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB436 - Analysis of Mesalazine(Under the Condition of the Japanese Pharmacopoeia, (7) Aniline) -

LC InertSearch InertSustain C18
LB435 - Analysis of Povidone(Under the Condition of the Japanese Pharmacopoeia 17th edition, (6) 2-Pyrrolidone) -

LC InertSearch InertSustain AQ-C18
LB433 - Analysis of Povidone(Under the Condition of the Japanese Pharmacopoeia 17th edition, (4) 1-Vinyl-2-pyrrolidone) -

LC InertSearch InertSustain AQ-C18
LB432 - Analysis of Haloperidol(Under the Condition of the Japanese Pharmacopoeia 17th edition, Haloperidol Tablets) -

LC InertSearch Inertsil ODS-4
LB431 - Analysis of Haloperidol(Under the Condition of the Japanese Pharmacopoeia 17th edition) -

LC InertSearch Inertsil ODS-4
LB430 - Analysis of Tulobuterol Hydrochloride(Under the Condition of the Japanese Pharmacopoeia 17th edition) -

LC InertSearch InertSustain C18
LB429 - Analysis of Tulobuterol(Under the Condition of the Japanese Pharmacopoeia 17th edition) -

LC InertSearch InertSustain C18
LB428 - Analysis of Zonisamide -

LC InertSearch InertSustain AQ-C18
LB427 - Analysis of Zonisamide -

LC InertSearch InertSustain AQ-C18
LB426 - Analysis of Diflorason Diacetate(Under the Condition of the Japanese Pharmacopoeia 17th edition) -

LC InertSearch InertSustain C18
LB425 - Analysis of Diflorason Diacetate(Under the Condition of the Japanese Pharmacopoeia 17th edition) -

LC InertSearch InertSustain C18
LB424 - Analysis of Eplerenone(Under the Condition of the Japanese Pharmacopoeia 17th edition, Eplerenone Tablets) -

LC InertSearch Inertsil ODS-3
LB423 - Analysis of Nonsteroidal anti-inflammatory drug （InertSustain Phenyl） -

LC InertSearch InertSustain Phenyl
LB422 - Analysis of Nonsteroidal anti-inflammatory drug （InertSustain C18） -

LC InertSearch InertSustain C18
LB421 - Analysis of Nonsteroidal anti-inflammatory drug （InertSustain Phenylhexyl） -

LC InertSearch InertSustain Phenylhexyl
LB420 - Analysis of Acetaminophen (Under the Condition of the Japanese Pharmacopoeia) （InertSustainSwift C18） -

LC InertSearch InertSustainSwift C18
LB419 - Analysis of Acetaminophen (Under the Condition of the Japanese Pharmacopoeia) （InertSustain C18） -

LC InertSearch InertSustain C18
LB418 - Analysis of Vitamin K (Inertsil WP300 C18) -

LC InertSearch Inertsil WP300 C18
LB417 - Analysis of Vitamin K (InertSustainSwift C18) -

LC InertSearch InertSustainSwift C18
LB416 - Analysis of Vitamin K (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB415 - Analysis of Methotrexate (Under the Condition of the draft for the Japanese Pharmacopoeia, Methotrexate Tablets) -

LC InertSearch Inertsil ODS-4
LB414 - Analysis of Esomeprazole magnesium (Under the Condition of USP 38-NF33, Esomeprazole magnesium Extended-release Tablets) -

LC InertSearch InertSustain C18
LB413 - Analysis of Eplerenone (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch InertSustainSwift C18
LB412 - Analysis of Eplerenone (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch InertSustainSwift C18
LB411 - Analysis of Medroxyprogesterone acetate (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch Inertsil WP300 C18
LB410 - Analysis of Medroxyprogesterone acetate (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch Inertsil WP300 C18
LB409 - Analysis of Mesalazine (Under the Condition of the draft for the Japanese Pharmacopoeia, Mesalazine Extended-release Tablets) -

LC InertSearch Inertsil ODS-4
LB408 - Analysis of Fluconazole (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustainSwift C18
LB407 - Analysis of Fluconazole (Under the Condition of the Japanese Pharmacopoeia, Fluconazole Capsules) -

LC InertSearch Inertsil WP300 C18
LB406 - Analysis of Hippuric acid -

LC InertSearch InertSustain AQ-C18 HP
LB405 - Analysis of Phenolic antioxidants -

LC InertSearch InertSustainSwift C18
LB404 - Analysis of Preservatives and Sweetener (Inertsil ODS-SP) -

LC InertSearch Inertsil ODS-SP
LB403 - Analysis of Preservatives and Sweetener (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB402 - Analysis of Preservatives and Sweetener (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB401 - Analysis of Preservatives and Sweetener (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB400 - Analysis of 9 Drugs (InertSustain C18) -

LC InertSearch InertSustain C18
LB399 - Analysis of 9 Drugs (InertSustainSwift C18) -

LC InertSearch InertSustainSwift C18
LB398 - Analysis of 9 Drugs (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB396 - Analysis of Oligonucleotide -

LC InertSearch InertSustainBio C18
LB395 - Analysis of Acetaminophen and Caffeine -

LC InertSearch InertSustainSwift C18
LB394 - Analysis of Methacrylic acid (InertSustain C18) -

LC InertSearch InertSustain C18
LB393 - Analysis of Methacrylic acid (InertSustainSwift C18) -

LC InertSearch InertSustainSwift C18
LB392 - Analysis of Methacrylic acid (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB386 - Analysis of Angiotensin II receptor blockers (Inertsil ODS-SP) -

LC InertSearch Inertsil ODS-SP
LB385 - Analysis of Angiotensin II receptor blockers (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB384 - Analysis of Angiotensin II receptor blockers (Inertsil ODS-3) -

LC InertSearch Inertsil ODS-3
LB383 - Analysis of Angiotensin II receptor blockers (InertSustainSwift C18) -

LC InertSearch InertSustainSwift C18
LB382 - Analysis of Angiotensin II receptor blockers (InertSustain C18) -

LC InertSearch InertSustain C18
LB381 - Analysis of Angiotensin II receptor blockers (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB380 - Analysis of ATP related compounds -

LC InertSearch InertSustain AQ-C18
LB378 - Analysis of Hippuric Acids -

LC InertSearch InertSustain AQ-C18 HP
LB377 - Analysis of 13 kinds of Aldehydes (Directed by Pre-Column Method with DNPH) -

LC InertSearch InertSustain AQ-C18 HP
LB375 - Analysis of Lidocaine -

LC InertSearch InertSustain C18
LB374 - Analysis of Ampiroxicam (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil WP300 C18
LB373 - Analysis of Cyclophosphamide (Under the Condition of the Japanese Pharmacopoeia, Cyclophosphamide Tablets) -

LC InertSearch InertSustainSwift C18
LB372 - Analysis of Cyclophosphamide (Under the Condition of the Japanese Pharmacopoeia, Cyclophosphamide Tablets) -

LC InertSearch InertSustainSwift C18
LB371 - Analysis of Amlodipine besilate (Under the Condition of the Japanese Pharmacopoeia, Amlodipine Besilate Orally Disintegrating Tablets) -

LC InertSearch InertSustainSwift C18
LB370 - Analysis of Prednisolone (Under the Condition of European Pharmacopoeia 8.2) -

LC InertSearch Inertsil ODS-3
LB369 - Analysis of Capsaicin (Under the Condition of the Japanese Pharmacopoeia, Capsicum Tincture) -

LC InertSearch InertSustain Phenyl
LB368 - Analysis of Nucleoside and Nucleic acid base (InertSustain C18) -

LC InertSearch InertSustain C18
LB367 - Analysis of Nucleoside and Nucleic acid base (InertSustain C18) -

LC InertSearch InertSustain C18
LB366 - Analysis of Nucleoside and Nucleic acid base (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB365 - Analysis of Nucleoside and Nucleic acid base (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB364 - Analysis of Water-soluble Vitamins -

LC InertSearch InertSustain AQ-C18
LB363 - Analysis of Organic acid -

LC InertSearch InertSustain AQ-C18
LB362 - Analysis of β-blocker -

LC InertSearch InertSustain AQ-C18
LB361 - Analysis of Furfral and 5-Hydroxymethylfurfral (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB360 - Analysis of Roxithromycin (Under the Condition of the Japanese Pharmacopoeia, Roxithromycin Tablets) -

LC InertSearch InertSustain C18
LB359 - Analysis of EPA and DHA -

LC InertSearch InertSustain C18
LB358 - Analysis of EPA and DHA (InertSustain C18) -

LC InertSearch InertSustain C18
LB357 - Analysis of EPA and DHA (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB356 - Analysis of EPA and DHA (Inertsil ODS-3) -

LC InertSearch Inertsil ODS-3
LB355 - Analysis of 7 fatty acids -

LC InertSearch InertSustain C18
LB354 - Analysis of 7 fatty acids -

LC InertSearch InertSustain C18
LB353 - Analysis of 7 fatty acids -

LC InertSearch InertSustain C18
LB352 - Analysis of 7 fatty acids (InertSustain C18) -

LC InertSearch InertSustain C18
LB351 - Analysis of 7 fatty acids (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB350 - Analysis of 7 fatty acids (Inertsil ODS-3) -

LC InertSearch Inertsil ODS-3
LB349 - Analysis of Sodium Propionate (InertSustain C18) -

LC InertSearch InertSustain C18
LB348 - Analysis of Sodium Propionate (Inertsil ODS-3) -

LC InertSearch Inertsil ODS-3
LB343 - Analysis of Furfral and 5-Hydroxymethylfurfral (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB342 - Analysis of Furfral and 5-Hydroxymethylfurfral (InertSustainSwift C18) -

LC InertSearch InertSustainSwift C18
LB341 - Analysis of Furfral and 5-Hydroxymethylfurfral (InertSustain C18) -

LC InertSearch InertSustain C18
LB340 - Analysis of Chelating compounds -

LC InertSearch InertSustain C18
LB339 - Analysis of Rebamipide (Under the Condition of the Japanese Pharmacopoeia, Rebamipide Tablets) -

LC InertSearch InertSustain C18
LB338 - Analysis of Chlorhexidine gluconate solution -

LC InertSearch Inertsil ODS-4
LB335 - Analysis of Taurine derivatized with Dansyl Chloride (DNS-Cl) -

LC InertSearch InertSustain C18
LB334 - Analysis of Acrylamide, Acrylonitrile and Organic acids -

LC InertSearch Inertsil ODS-4
LB333 - Analysis of Amygdalin (Inertsil NH2) -

LC InertSearch Inertsil NH2
LB330 - Analysis of Roxithromycin (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB329 - Analysis of Roxithromycin (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustainSwift C18
LB328 - Analysis of Roxithromycin (Under the Condition of the Japanese Pharmacopoeia 16th edition supplement II) -

LC InertSearch InertSustainSwift C18
LB327 - Analysis of Roxithromycin (Under the Condition of the Japanese Pharmacopoeia 16th edition) -

LC InertSearch InertSustainSwift C18
LB326 - Analysis of o-Phthalaldehyde (Directed by Pre-Column Method with DNPH) -

LC InertSearch InertSustainSwift C18
LB325 - Analysis of Glutaraldehyde (Directed by Pre-Column Method with DNPH) -

LC InertSearch InertSustainSwift C18
LB324 - Analysis of 16 kinds of Aldehydes (Directed by Pre-Column Method with DNPH) -

LC InertSearch InertSustainSwift C18
LB323 - Analysis of components of coffee in canned coffee (Inertsil ODS-4 ) -

LC InertSearch Inertsil ODS-4
LB321 - Analysis of components of coffee (Inertsil ODS-4 ) -

LC InertSearch Inertsil ODS-4
LB319 - Analysis of Maleic acid, Fumaric acid and Acrylic acid (Inertsil WP300 C18) -

LC InertSearch Inertsil WP300 C18
LB318 - Analysis of Maleic acid, Fumaric acid and Acrylic acid (InertSustainSwift C18) -

LC InertSearch InertSustainSwift C18
LB317 - Separation of Triacylglycerol Positional Isomer -

LC InertSearch Inertsil ODS-P
LB314 - Analysis of Acesulfame potassium (InertSustain C18) (Under the Condition of the JSFA-VIII (Japanese Standards of Food Additives)) -

LC InertSearch InertSustain C18
LB313 - Analysis of Acesulfame potassium (Inertsil ODS-3) (Under the Condition of the JSFA-VIII (Japanese Standards of Food Additives)) -

LC InertSearch Inertsil ODS-3
LB312 - Analysis of Acesulfame potassium (InertSustain C18) (Under the Condition of the JPE (Japanese Pharmaceutical Excipients)) -

LC InertSearch InertSustain C18
LB311 - Analysis of Acesulfame potassium (Inertsil ODS-3) (Under the Condition of the JPE (Japanese Pharmaceutical Excipients)) -

LC InertSearch Inertsil ODS-3
LB310 - Analysis of Voriconazole (Under the Condition of the Japanese Pharmacopoeia, Voriconazole Tablets) -

LC InertSearch Inertsil WP300 C18
LB309 - Analysis of Voriconazole (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil WP300 C18
LB308 - Analysis of Hydrochlorothiazide (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil ODS-4
LB307 - Analysis of Candesartan cilexetil (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil ODS-4
LB306 - Analysis of Hydrochlorothiazide (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil ODS-4
LB305 - Analysis of Candesartan cilexetil (Inertsil WP300 C18) (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil WP300 C18
LB304 - Analysis of Candesartan cilexetil (Inertsil ODS-3) (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil ODS-3
LB303 - Analysis of Hydrochlorothiazide (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil ODS-4
LB302 - Analysis of Candesartan cilexetil (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil ODS-4
LB301 - Analysis of Hydrochlorothiazide (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil ODS-4
LB300 - Analysis of Candesartan cilexetil (Inertsil WP300 C18) (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil WP300 C18
LB299 - Analysis of Candesartan cilexetil (Inertsil ODS-3) (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil ODS-3
LB298 - Analysis of Candesartan cilexetil (Inertsil WP300 C18) (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil WP300 C18
LB297 - Peptide Separation of Casein Tryptic Digests by Preparative HPLC ODS Column (20 mm I.D.) -

LC InertSearch Inertsil ODS-3
LB295 - Analysis of Irbesartan (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB294 - Analysis of Montelukast sodium -

LC InertSearch InertSustain Phenylhexyl
LB291 - Analysis of Ticlopidine hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Ticlopidine hydrochloride Tablets) -

LC InertSearch InertSustain C18
LB290 - Analysis of Cefalexin (Under the Condition of the Japanese Pharmacopoeia, Cefalexin Combination Granules) -

LC InertSearch InertSustain C18
LB286 - Analysis of Ribavirin (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4 HP
LB285 - Analysis of Ribavirin (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4 HP
LB284 - Analysis of Silodosin (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB283 - Analysis of Silodosin (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB282 - Analysis of Povidone (Under the Condition of the Japanese Pharmacopoeia 16th edition, (4) 1-Vinyl-2-pyrrolidone) -

LC InertSearch InertSustain C8
LB281 - Analysis of Montelukast sodium (Inertsil Ph) (Under the Condition of the Japanese Pharmacopoeia, Montelukast sodium Tablets) -

LC InertSearch Inertsil Ph
LB279 - Analysis of Indometacin (Under the Condition of European Pharmacopoeia 8.2) -

LC InertSearch InertSustain Phenylhexyl
LB278 - Analysis of Calcium antagonist -

LC InertSearch InertSustain Phenylhexyl
LB277 - Analysis of β-blocker -

LC InertSearch InertSustain Phenylhexyl
LB276 - Analysis of Anti-depressant drugs -

LC InertSearch InertSustain Phenylhexyl
LB275 - Analysis of Histamine antagonist -

LC InertSearch InertSustain Phenylhexyl
LB274 - Analysis of Capsaicin -

LC InertSearch InertSustain Phenylhexyl
LB273 - Analysis of Vitamin B -

LC InertSearch InertSustain Phenylhexyl
LB272 - Analysis of Ibuprofen and Indometacin -

LC InertSearch InertSustain Phenylhexyl
LB270 - Analysis of β-blocker -

LC InertSearch InertSustainSwift C18
LB265 - Analysis of Tacrolimus (Under the Condition of the Japanese Pharmacopoeia, Tacrolimus Capsules) -

LC InertSearch Inertsil ODS-2
LB264 - Analysis of Losartan Potassium and Hydrochlorothiazide (Under the Condition of the Japanese Pharmacopoeia, Losartan Potassium and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil C8-3
LB262 - Analysis of Losartan Potassium and Hydrochlorothiazide (Under the Condition of the Japanese Pharmacopoeia, Losartan Potassium and Hydrochlorothiazide Tablets) -

LC InertSearch InertSustain C8
LB257 - Analysis of Nucleobase (InertSustain Phenyl) -

LC InertSearch InertSustain Phenyl
LB256 - Analysis of Nucleobase (InertSustain C18) -

LC InertSearch InertSustain C18
LB254 - Analysis of Brotizolam (Under the Condition of the Japanese Pharmacopoeia, Brotizolam Tablets) -

LC InertSearch Inertsil WP300 C18
LB253 - Analysis of Tranilast (Under the Condition of the Japanese Pharmacopoeia, Tranilast Capsules) -

LC InertSearch InertSustain C18
LB252 - Analysis of Glimepiride -

LC InertSearch Inertsil Diol
LB251 - Analysis of Quetiapine fumarate (Under the Condition of the Japanese Pharmacopoeia, Quetiapine fumarate Tablets) -

LC InertSearch Inertsil C8-4
LB250 - Analysis of Azelnidipine (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB249 - Analysis of Organic electroluminescence materials -

LC InertSearch Inertsil ODS-3V
LB248 - Analysis of Organic electroluminescence materials -

LC InertSearch Inertsil ODS-3V
LB247 - Analysis of Terbinafine hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Terbinafine hydrochloride Cream) -

LC InertSearch InertSustainSwift C18
LB246 - Analysis of L-Carbocisteine (Under the Condition of the Japanese Pharmacopoeia, L-Carbocisteine Tablets) -

LC InertSearch Inertsil ODS-4
LB245 - Analysis of L-Carbocisteine (Under the Condition of the Japanese Pharmacopoeia, L-Carbocisteine Tablets) -

LC InertSearch Inertsil ODS-4
LB243 - Analysis of Acarbose (Under the Condition of the Japanese Pharmacopoeia, Acarbose Tablets) -

LC InertSearch Inertsil WP300 C18
LB242 - Analysis of Preservatives and Sweetener (Inertsil Ph) -

LC InertSearch Inertsil Ph
LB241 - Analysis of Preservatives and Sweetener (InertSustain C18) -

LC InertSearch InertSustain C18
LB240 - Analysis of Preservatives and Sweetener (InertSustain Phenyl) -

LC InertSearch InertSustain Phenyl
LB239 - Analysis of Preservatives and Sweetener (InertSustainSwift C18) -

LC InertSearch InertSustainSwift C18
LB238 - Analysis of Preservatives and Sweetener (InertSustain Phenylhexyl) -

LC InertSearch InertSustain Phenylhexyl
LB237 - Analysis of Preservatives and Sweetener (InertSustain C18) -

LC InertSearch InertSustain C18
LB236 - Analysis of Preservatives and Sweetener (InertSustainSwift C18) -

LC InertSearch InertSustainSwift C18
LB235 - Analysis of Preservatives and Sweetener (InertSustain Phenylhexyl) -

LC InertSearch InertSustain Phenylhexyl
LB234 - Analysis of Amino acids -

LC InertSearch InertSustainSwift C18
LB233 - Analysis of Amino acids -

LC InertSearch InertSustainSwift C18
LB232 - Analysis of Leuprorelin acetate (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustainSwift C18 HP
LB231 - Analysis of Leuprorelin acetate (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustainSwift C18 HP
LB230 - Analysis of Leuprorelin acetate (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustainSwift C18 HP
LB228 - Analysis of Polyvinyl alcohol, Polyethyleneglycol and Graft copolymer (Under the Condition of the JPE (Japanese Pharmaceutical Excipients), (3) Acetic acid) -

LC InertSearch InertSustain C18
LB227 - Analysis of Tocopherol (Inertsil ODS-2) -

LC InertSearch Inertsil ODS-2
LB226 - Analysis of Tocopherol (Inertsil ODS-3) -

LC InertSearch Inertsil ODS-3
LB225 - Analysis of Tocopherol (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB224 - Analysis of Tocopherol (InertSuatin C18) (Under the Condition of the Japanese Pharmaceutical Codex) -

LC InertSearch InertSustain C18
LB223 - Analysis of Cilnidipine (Under the Condition of the Japanese Pharmacopoeia, Cilnidipine Tablets) -

LC InertSearch Inertsil ODS-4
LB222 - Analysis of Butenafine hydrochloride (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18 HP
LB217 - Analysis of 2 kinds of Aldehydes (Inersil ODS-P) (Directed by Pre-Column Method with DNPH) -

LC InertSearch Inertsil ODS-P
LB216 - Analysis of 2 kinds of Aldehydes (Inersil ODS-SP) (Directed by Pre-Column Method with DNPH) -

LC InertSearch Inertsil ODS-SP
LB215 - Analysis of 2 kinds of Aldehydes (Inersil ODS) (Directed by Pre-Column Method with DNPH) -

LC InertSearch Inertsil ODS
LB214 - Analysis of 2 kinds of Aldehydes (Inersil ODS-2) (Directed by Pre-Column Method with DNPH) -

LC InertSearch Inertsil ODS-2
LB213 - Analysis of 2 kinds of Aldehydes (Inersil ODS-3) (Directed by Pre-Column Method with DNPH) -

LC InertSearch Inertsil ODS-3
LB212 - Analysis of 2 kinds of Aldehydes (Inersil ODS-4) (Directed by Pre-Column Method with DNPH) -

LC InertSearch Inertsil ODS-4
LB211 - Analysis of 2 kinds of Aldehydes (InertSustain C18) (Directed by Pre-Column Method with DNPH) -

LC InertSearch InertSustain C18
LB210 - Analysis of Pioglitazone hydrochloride (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB209 - Analysis of Pioglitazone hydrochloride (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB208 - Analysis of Montelukast sodium (Oxidative degradation products) -

LC InertSearch InertSustain Phenyl
LB207 - Analysis of Montelukast sodium -

LC InertSearch InertSustain Phenyl
LB205 - Analysis of Paroxetine hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Paroxetine hydrochloride Tablets) -

LC InertSearch Inertsil TMS
LB204 - Analysis of Metformin hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Metformin hydrochloride Tablets) -

LC InertSearch InertSustain C18
LB203 - Analysis of Candesartan cilexetil (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil Tablets) -

LC InertSearch Inertsil ODS-3
LB202 - Analysis of Candesartan cilexetil (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil Tablets) -

LC InertSearch Inertsil ODS-3
LB201 - Analysis of Candesartan cilexetil (Inertsil ODS-3) (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-3
LB200 - Analysis of Losartan potassium and Hydrochlorothiazide (Under the Condition of USP 35-NF30, Losartan potassium and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil C8-3
LB196 - Analysis of Ciprofloxacin hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Ciprofloxacin hydrochloride hydrate) -

LC InertSearch InertSustain C18
LB195 - Analysis of Metformin hydrochloride (InertSustain C8) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch InertSustain C8
LB194 - Analysis of Metformin hydrochloride (Inertsil C8-3) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch Inertsil C8-3
LB193 - Analysis of Pioglitazone hydrochloride (InertSustain C8) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch InertSustain C8
LB192 - Analysis of Pioglitazone hydrochloride (Inertsil C8-3) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch Inertsil C8-3
LB191 - Analysis of Metformin hydrochloride (InertSustain C8) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch InertSustain C8
LB190 - Analysis of Metformin hydrochloride (Inertsil C8-3) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch Inertsil C8-3
LB189 - Analysis of Pioglitazone hydrochloride (InertSustain C8) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch InertSustain C8
LB188 - Analysis of Pioglitazone hydrochloride (Inertsil C8-3) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch Inertsil C8-3
LB187 - Analysis of Chlorpheniramine maleate (Under the Condition of the Japanese Pharmacopoeia,Chlorpheniramine maleate Tablets) -

LC InertSearch InertSustain C18
LB186 - Analysis of Chlorpheniramine maleate (Under the Condition of the Japanese Pharmacopoeia,Chlorpheniramine maleate Tablets) -

LC InertSearch InertSustain C18
LB185 - Analysis of Chlorpheniramine maleate (Under the Condition of the Japanese Pharmacopoeia,Chlorpheniramine maleate Tablets) -

LC InertSearch InertSustain C18
LB184 - Analysis of Phellodendron Bark (Inertsil ODS-3) (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-3
LB183 - Analysis of Phellodendron Bark (InertSustain C18) (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB182 - Analysis of Glycyrrhiza (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB181 - Analysis of Glycyrrhiza (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB178 - Analysis of Hydrochlorothiazide -

LC InertSearch Inertsil WP300 C18
LB177 - Analysis of Povidone (Under the Condition of the draft for the Japanese Pharmacopoeia, (8) 2-pyrrolidone) -

LC InertSearch InertSustain C18
LB176 - Analysis of Povidone (Under the Condition of the draft for the Japanese Pharmacopoeia, (4) 1-Vinyl-2-pyrrolidone) -

LC InertSearch InertSustain C18
LB175 - Analysis of Loxoprofen (Under the Condition of the Japanese Pharmacopoeia, Loxoprofen sodium Tablets) -

LC InertSearch InertSustain C18
LB174 - Analysis of d-Chlorpheniramine maleate (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-3
LB173 - Analysis of Azelastine hydrochloride (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB167 - Analysis of Crospovidone (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB166 - Analysis of Pravastatin Sodium (Under the Condition of the Japanese Pharmacopoeia,Pravastatin Sodium Tablets) -

LC InertSearch Inertsil WP300 C18
LB165 - Analysis of Pravastatin Sodium (Under the Condition of the Japanese Pharmacopoeia, Pravastatin Sodium Tablets) -

LC InertSearch Inertsil ODS-4
LB164 - Analysis of Telmisartan (Under the Condition of the Japanese Pharmacopoeia, Telmisartan Tablets) -

LC InertSearch Inertsil ODS-4
LB163 - Analysis of Telmisartan (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-SP
LB162 - Analysis of Clopidogrel sulfate (Inertsil WP300 C18) (Under the Condition of the Japanese Pharmacopoeia, Clopidogrel sulfate Tablets) -

LC InertSearch Inertsil WP300 C18
LB160 - Analysis of Clopidogrel sulfate (Inertsil WP300 C18) (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil WP300 C18
LB159 - Analysis of Clopidogrel sulfate (InertSustain C18) (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB158 - Analysis of Clopidogrel sulfate (Inertsil WP300 C18) (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil WP300 C18
LB157 - Analysis of Clopidogrel sulfate (InertSustain C18) (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB156 - Analysis of Candesartan cilexetil (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Amlodipine besylate Tablets) -

LC InertSearch Inertsil ODS-4
LB155 - Analysis of Amlodipine besylate (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Amlodipine besylate Tablets) -

LC InertSearch Inertsil ODS-4
LB154 - Analysis of Candesartan cilexetil (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Amlodipine besylate Tablets) -

LC InertSearch Inertsil ODS-4
LB153 - Analysis of Candesartan cilexetil (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Amlodipine besylate Tablets) -

LC InertSearch Inertsil ODS-SP
LB152 - Analysis of Epinastine hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Epinastine Hydrochloride Tablets) -

LC InertSearch Inertsil C8-4
LB148 - Analysis of Cyanocobalamin (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C8
LB147 - Analysis of Allantoin -

LC InertSearch InertSustain NH2
LB146 - Analysis of Acesulfame potassium -

LC InertSearch InertSustain NH2
LB143 - Analysis of Nucleobase -

LC InertSearch InertSustain NH2
LB139 - Analysis of Nonsteroidal anti-inflammatory drug -

LC InertSearch InertSustain Phenyl
LB138 - Analysis of Steroidal anti-inflammatory drug -

LC InertSearch InertSustain Phenyl
LB137 - Analysis of Estrogen -

LC InertSearch InertSustain Phenyl
LB136 - Analysis of Cresol -

LC InertSearch InertSustain Phenyl
LB135 - Analysis of Methylhippuric acid -

LC InertSearch InertSustain Phenyl
LB134 - Analysis of Fexofenadine hydrochloride (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil Ph
LB133 - Analysis of Fexofenadine hydrochloride (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil Ph
LB128 - Analysis of Teprenone (Under the Condition of the Japanese Pharmacopoeia, Teprenone Capsules) -

LC InertSearch Inertsil ODS-2
LB127 - Analysis of Etizolam (Under the Condition of the Japanese Pharmacopoeia, Etizolam Tablets) -

LC InertSearch Inertsil ODS-3
LB126 - Analysis of Risperidone (Under the Condition of the Japanese Pharmacopoeia, Risperidone Tablets) -

LC InertSearch Inertsil WP300 C18
LB125 - Analysis of Risperidone (Under the Condition of the Japanese Pharmacopoeia, Risperidone Tablets) -

LC InertSearch Inertsil WP300 C18
LB124 - Analysis of Ipriflavone (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C8
LB123 - Analysis of Ipriflavone (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C8
LB122 - Analysis of Simvastatin (Under the Condition of the Japanese Pharmacopoeia, Simvastatin Tablets) -

LC InertSearch Inertsil WP300 C18
LB121 - Analysis of Simvastatin (Under the Condition of the Japanese Pharmacopoeia, Simvastatin Tablets) -

LC InertSearch Inertsil WP300 C18
LB120 - Analysis of Simvastatin (Under the Condition of the Japanese Pharmacopoeia, Simvastatin Tablets) -

LC InertSearch Inertsil WP300 C18
LB119 - Analysis of Glimepiride (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-3
LB118 - Analysis of Glimepiride (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-3
LB117 - Analysis of Mecobalamin (Under the Condition of the Japanese Pharmacopoeia, Mecobalamin Tablets) -

LC InertSearch Inertsil ODS-4
LB116 - Analysis of Mecobalamin (Under the Condition of the Japanese Pharmacopoeia, Mecobalamin Tablets) -

LC InertSearch Inertsil ODS-4
LB115 - Analysis of Mecobalamin (Under the Condition of the Japanese Pharmacopoeia, Mecobalamin Tablets) -

LC InertSearch Inertsil ODS-4
LB114 - Analysis of Epalrestat (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB113 - Analysis of Epalrestat (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB112 - Analysis of Sivelestat sodium hydrate (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB111 - Analysis of Sivelestat sodium hydrate (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB110 - Analysis of Organic acids (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB109 - Analysis of Organic acids (InertSustain C18) -

LC InertSearch InertSustain C18
LB106 - Analysis of Pitavastatin calcium tablets (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB105 - Analysis of Pitavastatin calcium -

LC InertSearch Inertsil ODS-4
LB104 - Analysis of Pitavastatin calcium (Under the Condition of the Japanese Pharmacopoeia, Pitavastatin calcium hydrate) -

LC InertSearch Inertsil ODS-4
LB103 - Analysis of Pilsicainide hydrochloride hydrate (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB102 - Analysis of Donepezil hydrochloride (Under the Condition of Japanese Pharmacopoeia, Donepezil hydrochloride tablets) -

LC InertSearch Inertsil ODS-2
LB101 - Analysis of Brotizolam (Under the Condition of the Japanese Pharmacopoeia, Brotizolam tablets) -

LC InertSearch Inertsil WP300 C18
LB100 - Analysis of p-Hydroxybenzoic acid n-butyl ester (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB098 - Analysis of p-Hydroxybenzoic acid n-propyl ester (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB097 - Analysis of p-Hydroxybenzoic acid ethyl ester (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB096 - Analysis of p-Hydroxybenzoic acid methyl ester (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB095 - Analysis of Edaravone Injection (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil WP300 C18
LB093 - Analysis of Pranlukast hydrate (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C8
LB092 - Analysis of Edaravone (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-3
LB091 - Analysis of Sinigrin (Inertsil ODS-3) -

LC InertSearch Inertsil ODS-3
LB089 - Analysis of Phenylenediamine -

LC InertSearch Inertsil ODS-3
LB087 - Analysis of Naftopidil (Under the Condition of the Japanese Pharmacopoeia, Naftopidil Tablets) -

LC InertSearch InertSustain C18
LB086 - Analysis of Naftopidil (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB084 - Analysis of Olmesartan medoxomil (Under the Condition of United States Pharmacopeia 35-NF30) -

LC InertSearch InertSustain C18
LB083 - Analysis of Ranitidine hydrochloride (Under the Condition of Japanese Pharmacopoeia 16) -

LC InertSearch ODS
LB082 - Analysis of Sertraline hydrochloride (Under the Condition of European Pharmacopoeia 7.0) -

LC InertSearch Inertsil ODS-3
LB075 - Analysis of Venlafaxine (InertSustain C18) -

LC InertSearch InertSustain C18
LB074 - Analysis of Rabeprazol (InertSustain C18) -

LC InertSearch InertSustain C18
LB073 - Analysis of Irbesartan (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB072 - Analysis of Ezetimibe (Inertsil C8-4) -

LC InertSearch Inertsil C8-4
LB071 - Analysis of Esomeprazol (InertSustain C18) -

LC InertSearch InertSustain C18
LB069 - Analysis of Rosuvastatin Calcium -

LC InertSearch InertSustain C18
LB068 - Analysis of Olmesartan medoxomil -

LC InertSearch InertSustain C18
LB067 - Analysis of Aripiprazole -

LC InertSearch InertSustain C18
LB066 - Analysis of Mosapride Citrate Tablets (Under the Condition of Japanese Pharmacopoeia 16) -

LC InertSearch InertSustain C18
LB065 - Analysis of Brotizolam(Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil WP300 C8
LB064 - Analysis of Tranilast (Inertsil ODS-4)(Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB063 - Analysis of Tranilast (InertSustain C18)(Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB062 - Analysis of Cetiridine hydrochloride (Under the Condition of Japanese Pharmacopoeia, Cetiridine hydrochloride Tablets) -

LC InertSearch Inertsil C8-3
LB061 - Analysis of Sarpogrelate Hydrochloride (Under the Condition of Japanese Pharmacopoeia 16) -

LC InertSearch Inertsil ODS-2
LB060 - Analysis of Quetiapine Fumarate (Under the Condition of the Japanese Pharmacopoeia, Quetiapine Fumarate Tablets) -

LC InertSearch Inertsil C8-4
LB059 - Analysis of Quetiapine Fumarate (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil C8-4
LB058 - Analysis of Amlodipine Besilate (Under the Condition of Japanese Pharmacopoeia, Amlodipine Besilate Tablets) -

LC InertSearch InertSustain C18
LB057 - Analysis of Acetylcysteine (Under the Condition of Japanese Pharmacopoeia 16) -

LC InertSearch Inertsil ODS-4
LB056 - Analysis of Olopatadine hydrochloride(Under the Condition of Japanese Pharmacopoeia, Olopatadine hydrochloride Tablets) -

LC InertSearch InertSustain C8
LB055 - Analysis of Olopatadine hydrochloride (Under the Condition of Japanese Pharmacopoeia, Olopatadine hydrochloride Tablets) -

LC InertSearch InertSustain C8
LB054 - Analysis of Olopatadine hydrochloride(Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch InertSustain C8
LB052 - Analysis of Valsartan (Inertsil ODS-4) -

LC InertSearch InertSustain C18
LB051 - Analysis of Amlodipine (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB050 - Analysis of Pioglitazone(Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB049 - Analysis of Pioglitazone(Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB047 - Analysis of Preservatives (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB046 - Analysis of Preservatives (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB045 - Analysis of Preservatives (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB044 - Analysis of Pyridine derivatives (InertSustain C8) -

LC InertSearch InertSustain C8
LB037 - Analysis of Terbinafine HCl (Inertsil ODS-4) (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB036 - Analysis of Terbinafine HCl (Inertsil ODS-3) (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-3
LB035 - Analysis of Terbinafine HCl (InertSustain C18) (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB034 - Analysis of Nucleotides -

LC InertSearch InertSustain NH2
LB033 - Analysis of Vitamin E -

LC InertSearch InertSustain NH2
LB030 - Analysis of Vitamin K (InertSustain C8) -

LC InertSearch InertSustain C8
LB029 - Analysis of Pitavastatin Calcium -

LC InertSearch InertSustain C18
LB028 - Analysis of Pitavastatin Calcium -

LC InertSearch InertSustain C18
LB027 - Analysis of Pitavastatin Calcium -

LC InertSearch InertSustain C18
LB026 - Analysis of Pitavastatin Calcium -

LC InertSearch InertSustain C18
LB025 - Analysis of Atorvastatin Calcium (Under the Condition of Japanese Pharmacopoeia, Atorvastatin Calcium Hydrate) -

LC InertSearch InertSustain C18
LB024 - Analysis of Atorvastatin Calcium (Under the Condition of Japanese Pharmacopoeia, Atorvastatin Calcium Tablets) -

LC InertSearch InertSustain C18
LB023 - Analysis of Atorvastatin Calcium (Under the Condition of Japanese Pharmacopoeia, Atorvastatin Calcium Tablets) -

LC InertSearch InertSustain C18
LB022 - Analysis of Losartan potassium and Valsartan -

LC InertSearch InertSustain C18
LB021 - Analysis of Valsartan and Hydrochlorothiazide -

LC InertSearch InertSustain C18
LB020 - Analysis of Losartan Potassium and Hydrochlorothiazide -

LC InertSearch InertSustain C8
LB019 - Analysis of Losartan Potassium and Hydrochlorothiazide -

LC InertSearch Inertsil C8-4
LB018 - Analysis of Potassium ferricyanide and Potassium ferrocyanide -

LC InertSearch InertSustain C18
LB017 - Analysis of Furosemide(Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil WP300 C18
LB015 - Analysis of Ergosterol(Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB014 - Analysis of Ergosterol(InertSustain C18) -

LC InertSearch InertSustain C18
LB013 - Analysis of Iohexol and Iopamidol -

LC InertSearch InertSustain C18
LA559 - Analysis of Androsterone and Epiandrosterone -

LC InertSearch Inertsil ODS-3
LA522 - Analysis of Resveratrol -

LC InertSearch InertSustain C18
LA303 - Analysis of Pesticides -

LC InertSearch Inertsil ODS-3
LA302 - Analysis of Pesticides -

LC InertSearch Inertsil Ph
LA301 - Analysis of Pesticides -

LC InertSearch Inertsil Ph-3
GA227 - Pesticides -

GC InertSearch InertCap Pesticides
GA226 - Pesticides -

GC InertSearch InertCap Pesticides

Applications including "UV"

LT207 - Anaysis of Antioxidant capacity by post-column HPLC using DPPH radical -

LT205 - Anaysis of stable radical DPPH -

LT201 - Analysis of nitrosoamines by LC-MS / MS, HPLC using InertSustain AQ-C18 -Comparison with PFP column- -

LT198 - Analysis of ergothioneine in shiitake mushrooms by HPLC -

LT197 - Analysis of capsaicin by HPLC and LC/MS/MS -

LT195 - Eighteenth revision Japanese Pharmacopoeia analysis of tranexamic acid -2.00 Condition change within the range specified in the general chromatography- -

ST030 - Analysis of cyromazine in livestock products -

LB263 - Analysis of Losartan Potassium and Hydrochlorothiazide (Under the Condition of the Japanese Pharmacopoeia, Losartan Potassium and Hydrochlorothiazide Tablets) -

LB206 - Analysis of Paroxetine hydrochloride (Under the Condition of the Japanese Pharmacopoeia) -

LB161 - Analysis of Clopidogrel sulfate (InertSustain C18) (Under the Condition of the Japanese Pharmacopoeia, Clopidogrel sulfate Tablets) -

LB099 - Analysis of p-Hydroxybenzoic acid n-butyl ester (Under the Condition of Japanese Pharmacopoeia) -

LB094 - Analysis of Pranlukast hydrate (Under the Condition of the Japanese Pharmacopoeia) -

LB085 - Analysis of Olmesartan medoxomil (Under the Condition of the Japanese Pharmacopoeia) -

LB031 - Analysis of Preservatives and Sweetener -

LA908 - Analysis of 17 Anti-depressant drugs (InertSustain C18) -

LC110 - Analysis of Quinic acid, Malic acid, Citric acid, Shikimic acid (Under the Condition of draft for USP, Aronia melanocarpa Fruit Aqueous Dry Extract, IDENTIFICATION C.HPLC PROFILE AND RATIO OF ORGANIC ACIDS) -

LC109 - Analysis of Prazosin hydrochloride (Under the Condition of draft for USP, Prazosin Hydrochloride Compounded Oral Suspension, ASSAY) -

LC108 - Analysis of Formoterol fumarate (Under the Condition of draft for USP, Formoterol Fumarate Inhalation Solution, Assay) -

LC107 - Analysis of Terbinafine hydrochloride (Under the Condition of USP41-NF36,Terbinafine Tablets, IMPURITIES (LIMIT OF TERBINAFINE DIMER)) -

LC105 - Analysis of Cefalexin (Under the Condition of Japanese Pharmacopoeia 18th, Cefalexin,Purity(3) Related substances ) -

LC100 - Analysis of Omeprazole(Under the Condition of USP41-NF36, Omeprazole Delayed-Release Capsules, ASSAY) -

LC099 - Analysis of Ascorbic acid (Under the Condition of draft for USP, Water-Soluble Vitamins Chewable Gels, Ascorbic acid, Method 1) -

LC098 - Analysis of Tramadol Hydrochloride (Under the Condition of draft for USP, Tramadol Hydrochloride Tablets, ASSAY) -

LC096 - Analysis of Adapalene (Under the Condition of draft for USP, Adapalene Cream,ORGANIC IMPURITIES) -

LC095 - Analysis of Adapalene (Under the Condition of draft for USP, Adapalene Cream,ASSAY) -

LC094 - Analysis of Steroids -

LC093 - Analysis of Phytosterols -

LC092 - Analysis of Oligonucleotides -

LC091 - Analysis of Oligonucleotides -

LC090 - Analysis of Oligonucleotides -

LC089 - Analysis of Nucleobases and Nucleosides -

LC088 - Analysis of Nucleobases and Nucleosides -

LC087 - Analysis of Coenzyme A (CoA) -

LC086 - Analysis of Antiviral drugs -

LC085 - Analysis of Antiviral drug nucleosides -

LC084 - Analysis of Antihistamines -

LC083 - Analysis of Antidepressants -

LC082 - Analysis of phytosterols -

LC081 - Analysis of 16 kinds of Aldehydes(Detected by Pre-Column Method with DNPH) -

LC080 - Analysis of Nucleobases and Nucleosides -

LC079 - Analysis of Decitabine -

LC078 - Analysis of Cyclic nucleotides -

LC077 - Analysis of Components of coffee -

LC076 - Analysis of Antiviral drugs -

LC075 - Analysis of Antiviral drugs -

LC074 - Analysis of Abscisic acid -

LC073 - Analysis of Yohimbine Hydrochloride(Under the Condition of USP41-NF36,Yohimbine Injection, ASSAY) -

LC072 - Analysis of Vitamin K１ (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,PHYTONADIONE) -

LC071 - Analysis of Acetaminophen(Under the Condition of USP41-NF36, Acetaminophen Oral Solution, ASSAY) -

LC070 - Analysis of Vitamin A (Under the Condition of USP4１-NF3６, Oil- and Water-Soluble Vitamins Capsules,Vitamin A,Method 1) -

LC069 - Analysis of Catecholamines and it's Metabolites -

LC068 - Analysis of Gliclazide (Under the Condition of the draft for Japanese Pharmacopoeia, Gliclazide Tablets, ASSAY) -

LC067 - Analysis of Rebamipide (Under the Condition of the Japanese Pharmacopoeia 18th, Rebamipide, Purity (4) Related Substances -

GA388 - Analysis of Pesticides -

LC064 - Analysis of Pioglitazone Hydrochloride and Glimepiride (Under the Condition of the Japanese Pharmacopoeia 18th, Pioglitazone Hydrochloride and Glimepiride Tablets, ASSAY(2)Glimepiride) -

LC063 - Analysis of Pioglitazone Hydrochloride and Glimepiride (Under the Condition of the Japanese Pharmacopoeia 18th, Pioglitazone Hydrochloride and Glimepiride Tablets, ASSAY(1)Pioglitazone Hydrochloride) -

LC060 - Analysis of Aspirin (Under the Condition of the draft for the Japanese Pharmacopoeia 19th, Aspirin Delayed-release Tablets, ASSAY) -

LC059 - Analysis of 1-Fluoro-2,4-dinitrophenyl-5-L-alaninamide (Under the Condition of the draft for the Japanese Pharmacopoeia 19th, Pregabalin, 1-Fluoro-2,4-dinitrophenyl-5-L-alaninamide, Assay) -

LC057 - Analysis of Methocarbamol (Under the Condition of USP43-NF38, Methocarbamol Tablets, ASSAY) -

LC056 - Analysis of Methocarbamol (Under the Condition of USP43-NF38, Methocarbamol, ASSAY) -

LC055 - Analysis of Dobutamine (Under the Condition of the USPNF 2023 Issue 2, Dobutamine Hydrochloride, ASSAY) -

LC054 - Analysis of Methocarbamol (Under the Condition of USP43-NF38, Methocarbamol Injection, ASSAY) -

LC048 - Analysis of Homocysteine -

LC047 - Analysis of Homocysteine -

LC043 - Analysis of Semaglutide and Tirzepatide -

LC040 - Analysis of Acetaminophen (Under the Condition of the USPNF2023 Issue 1, Acetaminophen, IMPURITIES, Limit of Free 4-Aminophenol) -

LC039 - Analysis of Acetaminophen (Under the Condition of the USPNF2023 Issue 1, Acetaminophen, ASSAY) -

LC037 - Analysis of Amlodipine Besilate (Under the Condition of the Japanese Pharmacopoeia 18th, Amlodipine Besilate, Purity(2) Related Substances) -

LC025 - Analysis of Eplerenone (Under the Condition of draft for USP, Eplerenone Tablets, ASSAY) -

LC024 - Analysis of Eplerenone (Under the Condition of draft for USP, Eplerenone, ASSAY) -

LC023 - Analysis of Lansoprazole (Under the Condition of the USP41-NF36, Lansoprazole Compounded Oral Suspension, ASSAY) -

LC022 - Analysis of Ursodeoxycholic acid (Under the Condition of the Japanese Pharmacopoeia 18th, Ursodeoxycholic acid Tablets, Ursodeoxycholic acid Granules) -

LC019 - Analysis of Aspartame and L-α-Aspartyl-D-phenylalanine Methyl Ester -

LC018 - Analysis of L-α-Aspartyl-D-phenylalanine Methyl Ester (Japan’s Standards and Specifications for Food Additives (10th ed.), Aspartame, Purity(5)) -

LC010 - Analysis of Imazalil (Under the Condition of food additive analysis method in food, Imazalil) -

LC007 - Analysis of Olanzapine -

LC006 - Analysis of Benzoyl Peroxide（Under the Condition of food additive analysis method in food, Benzoyl peroxide) -

LC005 - Carbamazepine -

LC004 - Analysis of Urea and Thiourea -